Home Blog Page 102

Senegal Detects First Case of Omicron COVID-19 Variant

0

 

Senegal detects first case of Omicron COVID-19 variant

 

A first case of the Omicron variant of COVID-19 has been reported in Senegal, in a visitor who was leaving the country after an international meeting in capital Dakar, a research institute said.

The IRESSEF health body said late Saturday that the 58-year-old patient arrived in Senegal by air from another West African country on November 22.

He had been vaccinated earlier this year with the AstraZeneca and Pfizer shots and had no symptoms by Saturday.

Although the man has now been quarantined in a medical centre, he stayed at a Dakar hotel and took part in an event with 300 people from different countries on November 24-25.

Senegal has recorded more than 74,000 coronavirus cases since the pandemic began.

Launched in February, the country’s vaccination campaign has made slow progress, with 1.3 million people inoculated out of a total 17 million population.

(AFP)

Fauci to Speak at Nigeria’s COVID-19 Summit

0
Mr Anthony Fauci.

As part of efforts to redefine the country’s national COVID-19 response and build the health security framework for the country, the Nigerian COVID-19 Summit is to host Anthony Fauci.

Mr Fauci, who is the Chief Medical Adviser to the U.S. President Joe Biden as well as the Director, the National Institute of Allergy and Infectious Diseases, U.S., will be speaking at the summit.

The summit, which is in partnership with the Coalition of Development Partners, will be holding from December 6 to December 8, 2021 in Abuja.

Mukhtar Muhammed, Technical Head, Presidential Steering Committee (PSC) on COVID-19, made the disclosure to the News Agency of Nigeria (NAN) in Abuja on Sunday.

Mr Mohammed said that the PSC had also mobilised all critical stakeholders including development partners for this important National Summit.

“We are heartened and encouraged by the support we have received so far from our development partners and the private sector.

“With just one day away from the commencement of this summit, which will help us to redefine our national COVID-19 response and build the health security framework for the country,” he added.

He, however, encouraged Nigerians and the international community to visit the website of this summit.

“There will be a virtual session that can be accessed by all. In order to register, you will log on to the website.

“I want to thank all Nigerians, members of the diplomatic corps for their understanding in our procedures.

“Our international development partners, for providing technical and financial support, members of the press, for doing your work to ensure that we advance the cause of public health, and Nigeria remains a very safe environment,” he said.

NAN reports that the Secretary to the Government of the Federation and Chairman PSC on COVID-19, Boss Mustapha, had said that in preparation of the committee’s winding down, it would hold a COVID-19, summit in partnership with the Coalition of Development Partners in the country.

According to Mr Mustapha, the theme of the summit will be: “Pushing through the Last Mile to End the Pandemic and Build Back Better”.

The sub-themes include: “Leadership And Governance In Pandemic Recovery And Reconstruction” and “Nigeria’s Health-Security Framework For Effective Response To Global Health Security Threats”.

The SGF noted that the summit would be an august assemblage of key actors in the health, economic, security, and policy-making sectors of the country.(NAN)

 

FG Approves COVID-19 Vaccines Booster for Nigerians

0
FG Approves COVID-19 Vaccines Booster for Nigerians
FG Approves COVID-19 Vaccines Booster for Nigerians

The Presidential Steering Committee (PSC) on COVID-19, has authorised vaccine booster against the pandemic for eligible Nigerians.

Dr Faisal Shuaib, the Executive Director, National Primary Healthcare Development Agency (NPHCDA), told the News Agency of Nigeria (NAN) on Friday in Abuja, that the decision was reached in collaboration with the Federal Ministry of Health and the agency.

Shauib said the decision reached was for the administration of booster doses for those that had completed the two doses of AstraZeneca, Moderna, Pfizer Bio-N-Tech or one dose of Johnson and Johnson.

The NPHCDA scribe said that the eligibility criteria for taking the booster dose include: any person of 18 years and above, time interval of six months or more after receiving the second dose of AstraZeneca, Moderna or Pfizer Bio-N-Tech.

“Time interval of two months or more after receiving the Johnson and Johnson vaccine.

“Consequent upon the above, eligible Nigerians are advised to visit the nearest health facility or mass vaccination sites for their booster doses as from Dec.10, 2021 across the 36 states of the federation and the FCT,” he said.

According to him, a COVID-19 booster dose gives greater protection against the virus.

He urged all Nigerians to take advantage of the opportunity offered by the Federal Government of Nigeria.

“The list of the vaccination sites is available on the NPHCDA website: www.nphcda.gov.ng

“For more information, contact the NPHCDA COVID-19 call center on 07002201122 for assistance,” Shauib advised. (NAN)

The Importance of Antioxidants to Health

0
    Chinma Ejimofor

The process of oxidation in the human body damages cell membranes and other structures, including cellular proteins, lipids and DNA. When oxygen is metabolised, it creates unstable molecules called “free radicals”, which steal electrons from other molecules, causing damage to DNA and other cells.

The body can cope with some free radicals and needs them to function effectively. However, the damage caused by an overload of free radicals over time (oxidative stress), may become irreversible and lead to certain diseases (including heart and liver disease) and some cancers (such as oral, oesophageal, stomach and bowel cancers).

Oxidation can be accelerated by stress, cigarette smoking, alcohol, sunlight, pollution and other factors.

 

Antioxidants and free radicals

Antioxidants are found in certain foods and may prevent or slow down some of the damage caused by free radicals by neutralising them. These include the nutrient antioxidants, vitamins A, C and E, and the minerals copper, zinc and selenium.

 

Other dietary food compounds, such as the phytochemicals in plants, are believed to have greater antioxidant effects than vitamins or minerals. These are called the non-nutrient antioxidants and include phytochemicals (such as lycopenes in tomatoes and anthocyanins found in cranberries). These plant-based antioxidants are a kind of phytonutrient and called exogenous source.

 

Antioxidants are called “free radical scavengers”. They mop up or fight free radicals in the body. Free radicals are also called reactive oxygen species (ROS). Antioxidants can be sourced naturally in brightly coloured fruits like pomegranates, pineapple etc. or through nutritional supplements. The body also produces some antioxidants, such as glutathione, lipoic acid, bilirubin, ferritin, superoxide dismutase, catalase, glutathione peroxidase, among others. These are called endogenous antioxidants.

 

Factors that increase the production of free radicals in the body can be internal, such as Inflammation; or external, for example, pollution, UV rays exposure, cigarette smoke, car and industrial fumes. Other factors which predispose us to oxidative stress include:

 

High fat diets

Excessive red meat

High levels of stress (busy executives)

Chemicals and preservatives in food

Processed and fast foods

Alcohol

Dairy products

Artificially ripened fruits

White flour and pastry products

Water pollution

Toxic wastes

Refined Sugar

 

Some conditions caused by free radicals include:

Deterioration of the eye lens, which contributes to vision loss.

Inflammation of the joints (arthritis).

Damage to nerve cells in the brain, which contributes to conditions such as Parkinson’s or Alzheimer’s disease.

Acceleration of the ageing process.

Increased risk of coronary heart disease, since free radicals encourage low-density lipoprotein (LDL) cholesterol to stick to artery walls.

Certain cancers triggered by damaged cell DNA.

 

The benefits of taking antioxidants, especially through organic nutritional supplements include the following:

 

Proper nutrition at cellular level.

The WHO recommends five daily servings of fruits and vegetables. Most people today cannot do this).

 

Supports kidney function

Maintains good dental health

Improves reproductive function

Improves nervous system functioning

Have anti-aging effects

Supports the immune system and improves defence power of the body

Protects the liver

Reduces obesity

Maintains healthy vision

Offers protection against digestive disorders

Improves quality of sleep

Supports the respiratory system.

 

Excellent nutritional supplements that can be recommended include the following products, all from the stable of the Aloe Vera Company. These are Aloe Vera Gel, Berry Nectar, Bits n Peaches, Pomesteen Power, Aloe Blossom Tea, SuperGreens, Daily, Ginchia, iVision, Vitolize Men and Women, Garlic Thyme, Immublend, Lycium Plus, Infinite Complex, Absorbent C and Argi Plus, just to mention a few.

 

References:

Google

Health Lecture by Adebayo Ijaoba

 

About the Author

Mrs Chima Ejimofor is the Lead Partner of Infinite Health Consult, and is available for the purchase of these Nutritional Supplements, Health Talks and Wellness Seminars. She is based in Lagos, Nigeria. Telephone/WhatsApp: 07033179632, email: infinitehealthconsult@gmail.com

Ohuabunwa Tasks ACPN Leadership on Dedication, Harmony

0
Pharm. Wale Oladigbolu, national chairman, ACPN, presenting a gift to the immediate past PSN president, Mazi Sam Ohuabunwa, with Pharm. Ambrose Eze, national secretary, and Pharm. (Mrs) Ashore Omokhafe, national treasurer, during the ACPN courtesy visit to the Pharmacy House on Wednesday.

The immediate past President, Pharmaceutical Society of Nigeria (PSN), Pharm. (Mazi) Sam Ohuabunwa, has advised the leadership of the Association of Community Pharmacists of Nigeria (ACPN) to remain committed to the goal of advancing the interests of the association, while remaining united, noting that the general acceptance of the new chairman, Pharm. Wale Oladigbolu, is an indication that ACPN is on the path of greatness.

The respected pharmacist said this during a recent courtesy visit by the national executive members of the ACPN, led by Oladigbolu, to the PSN National Secretariat, Pharmacy House, in Anthony, Lagos, few days before the expiration of Ohuabunwa’s tenure.

Addressing the delegation, the former PSN president debunked rumours of a rift the ACPN leadership, saying certain decisions he took were simply to correct isolated anomalies.

He said, “We thank God for the successful transition and for giving us a brand new leadership. The world is a dynamic place and one of the things that happen in life is that we do come and go. So the most important thing is to do our best when we have the opportunity, as history is always there to judge us on what we did and what we didn’t do well. But it becomes a problem when a human being attributes infallibility to himself; it is a bad thing.

“I am indulgent, I am tolerant, and I have a fatherly posture, but I believe in discipline because a society without discipline is bound to fail. Discipline is what keeps an association going and maintain regularity and credibility. So I think the issue on ground had been a personal issue all along; so it does not in any way affect the relationship between the PSN and ACPN.

Ohuabunwa added, “I have no issue with ACPN, as it’s a very important part of me as the PSN president, as a former chief executive officer of Neimeth, as a pharmacist and an elder in the profession. So I cannot have an issue with a technical arm as important as ACPN. Even if any issue arises at all, it has to be settled and we move on.”

Speaking further, Ohuabunwa urged the ACPN executives to be determined to do their best in rendering exceptional services, regardless of challenges, stressing that the reward of their service will come sooner or later.

Responding to the remarks, Oladigbolu said that the association’s visit was to show appreciation to him for his continual support and fatherly role over the years, adding that it was also to seek his elderly advice, while intimating him with the plans of the ACPN for the next three years.

Oladigbolu further noted that the visit was very significant, as it was his first visit to the PSN Secretariat since his assumption of office as national chairman.

The ACPN boss further seized the opportunity to state some of his administration’s plans, including the community pharmacy expansion scheme, the clean medicine initiative, the depth and growth of Pharmacy practice, as well as the leadership trust project, which he said the association will vigorously work on.

Oladigbolu said, “Our mission was to come with all our executive members, but due to distance issue, finances and other logistic reasons, we had to come as we are. We are here to seek your support as we hit the ground running on our programmes and as we plan to have our inauguration very soon.”

Others in attendance at the meeting were Pharm. Ambrose Eze, national secretary, ACPN; Pharm. Mrs Ashore Omokhafe, national treasurer, ACPN, and Pharm. Charles Oluwaseyi, head of admin, ACPN national secretariat.

NAFDAC Preparing Nigeria for Vaccine Production – Adeyeye

0
NAFDAC Authorises use of Moderna, AstraZeneca Vaccines, conditionally recommends Sputnik V
Prof. Moji Adeyeye

– Says COVID-19 has created exciting opportunities, strategies to tackle future challenges

The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Adeyeye, has said that the outbreak of the COVID-19 pandemic has strengthened its operations, saying NAFDAC has now moved to a higher level of efficiency, such that it is now preparing the country for vaccine manufacturing.

The NAFDAC DG, who was the keynote speaker at the 94th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Port Harcourt, Rivers State, spoke on “COVID-19 Lessons: Broadening and Strengthening the Nigerian Pharmaceutical/Health Sector”.

In her address, Adeyeye said although the pandemic wreaked a lot of havoc across the globe, it also heralded exciting opportunities that spurred creation of strategies and viable tools necessary to respond effectively to current challenges and also provide sustainable solution to future challenges.

According to the NAFDAC boss, COVID-19, which was first reported in China, in December 2019, and spread throughout the globe in less than three months, exacted enormous pressure and created challenges in many areas of the health sector, noting that it also caused disruptions of the socioeconomic wellbeing of the general public.

While analysing the effects of the deadly virus on the world, Adeyeye said COVID-19 created unprecedented pressure on healthcare systems and exposed the inability of the existing capacities to provide full and affordable access to quality healthcare. She added that the pandemic affected even the most resourceful and advanced healthcare systems in the world.

Adeyeye also said that uncertainties over how the pandemic would progress added further complexities to the uncertain healthcare environment, since there was no vaccine or effective treatment at the beginning. This, she said, affected health programmes planning and budgeting, adding that the disruption of the pharmaceutical supply chain, travel restrictions and lockdowns led to the disruption of medicine supplies.

Adeyeye said NAFDAC, in particular, was confronted with many challenges when the pandemic broke out in Nigeria. According to her, ensuring business continuity amid the restriction of movement, to guarantee continued availability and access to safe, quality and efficacious medical products, was one of the challenges the pandemic posed to it.

She said: “Disruption of the global pharmaceutical supply chain, due to travel restrictions/lockdowns and attendant shortages in medical product supplies; limited supply of COVID-19 related health products, due to disruption in the global supply chain and increase in demand for these products by the public; and the need to proactively fight the proliferation of substandard and falsified medical products due to surge in demand for COVID-related products are some of the challenges imposed on the agency by COVID-19.”

Other challenges imposed on NAFDAC by the pandemic, according to Adeyeye, include increase in regulatory workload due to large volume of applications for COVID-19 related products/consumables, health risks to NAFDAC’s frontline workforce that are ensuring NAFDAC’s business continuity in the ports and other formations, the need for the regulatory agency to proactively provide up-to-date guidance and regulations in response to the evolving crisis and to support the development and expedited approval of safe and efficacious treatments for COVID-19 and COVID-related infections.

She however noted that some of the moves and programmes that the agency was already embarking on before the pandemic broke out helped a lot to confront the global disease in Nigeria.

According to her, “In line with the agency’s mandate, policies, programmes and projects, measures had been in place to ensure ready access and quick availability of safe, efficacious and quality assured medical products.”

As part of the agency’s preparedness for emergency before the pandemic broke, Adeyeye noted that the agency had migrated from physical and manual processing to electronic processing of product registration and issuance of permit, adding that NAFDAC was already undergoing World Health Organisation benchmarking audit, while also having increased investment in regulatory infrastructure, and was set to be a reference listed regulatory authority (ML3).

According to Adeyeye, “NAFDAC leveraged its antecedents and existing infrastructure. We ensured that the nation’s pharmaceutical supply chain was not adversely affected. We ensured the availability of safe, effective and quality assured COVID-19 related products, vaccines and technologies.

“The agency also embraced business-continuity strategies, developed and implemented protocol for workplace preparedness and prevention of COVID-19 infection, ramped up the complete migration of all application submissions and processing to electronic platforms, deployed digital tools and expanded use of alternative regulatory approval pathways”.

The NAFDAC boss disclosed that before COVID-19, Nigeria had only 21 approved alcohol-based hand sanitizers. During the pandemic, however, 231 more were approved. She also said that before the pandemic, there was no approved locally made nose mask and other personal protective Equipment (PPE) in the country, noting that during the outbreak, 10 nose masks were approved and accordingly, the first NAFDAC-approved medical mask has been exported to the United States of America from Nigeria.

Adeyeye pointed out that NAFDAC now aims to have full visibility over all products moving within the pharmaceutical supply chain in Nigeria, having earlier instituted the Pharmaceutical Traceability Desk in 2019.

“The Nigeria National Pharmaceutical Traceability Strategy guided the development of a five-year implementation plan and it is the first step in positioning Nigeria to be a leader in driving the monitoring of regulated products supply chain or traceability of pharmaceuticals in Africa”, Adeyeye said.

To achieve the set goals, the NAFDAC DG also said the agency is currently collaborating with other agencies and institutions within and outside the country, including the National Primary Health Care Development Agency (NPHCDA), the Nigeria Centre for Disease Control (NCDC), the United Nations Children’s Fund (UNICEF), the United States Agency for International Development (USAID), African Union 3S (Smart, Safety, Surveillance), the Medicines and Healthcare products Regulatory Agency (MHRA), the Bill and Melinda Gates Foundation, the University of Maryland and the United States Centres for Disease Control and Prevention (US CDC).

Adeyeye averred, “The COVID-19 pandemic has disrupted pharmaceutical healthcare systems of all countries, irrespective of resourcefulness and advancement. For the pharmaceutical sector, there was disruption of the medical products supply chain and a sharp increase in the demand for COVID-19 related consumables.

“NAFDAC responded to these challenges, using its antecedents and infrastructure, by ensuring that the nation’s pharmaceutical supply chain was not adversely affected. Notwithstanding the numerous challenges, the pandemic has heralded exciting opportunities that spur the creation of strategies and the development of viable tools necessary to respond effectively and rapidly to current challenges and provide sustainable solutions to future challenges.”

She added, “NAFDAC’s regulatory preparedness guidance made the agency to be at high alert for the advent of COVID-19 vaccines. COVID-19 vaccine has been successfully used as a pilot for supply chain monitoring, using GS1-driven traceability, with Nigeria leading globally. Adverse events following Immunisation reporting has improved significantly, using Med Safety App.

“Reliance and collaboration have contributed to the relative success of the COVID-19 vaccine launch in Nigeria. Despite the pandemic, NAFDAC has moved from Machine Learning one (ML1) in 2018 to ML3, ready for assessment, thus preparing Nigeria for vaccine manufacturing.”

COVID-19 And Other Pandemics in History

0

The emergence and recurrence of infectious diseases has lent credence to the fact that nature is never static. It is also a warning signal to the scientific world to gear up for more complicated emergencies in future. The pharmaceutical and medical worlds, in particular, have to be ahead of the times, through cutting-edge research and drug development, to ensure that the world is not overwhelmed by any infectious disease.

In the history of mankind, infectious diseases have impacted humanity negatively, while equally opening up new vistas in pharmaceutical and medical researches. Unfortunately, mankind’s shift into agrarian life about 10, 000 years ago worsened the threats posed by these diseases. With human communities getting more connected, diseases like influenza, smallpox, leprosy, malaria, and tuberculosis wreaked great havoc and created a sense of trepidation among mankind.

The first historically documented pandemic occurred during the Peloponnesian War in Athens, Greece in 430 B.C. The disease was carried across the Athenian walls during the siege. According to historians, around two-thirds of the population died from the disease.

This was followed by the Antonine Plague, which emerged in 163 AD, and is now seen as an early version of smallpox. This plague started with the Huns infecting the Germans, who then passed it to the Romans. It was from the Romans that the plague spread throughout the entirety of the Roman Empire.

With the steady growth of human civilisations, which witnessed the conquest of empires around the world, infectious diseases gathered greater momentum to spread. In 541 A.D., the Justinian plague broke out in Egypt, spreading across Palestine and the Byzantine Empire, and eventually reaching the Mediterranean. This particular plague was significant with the impact it had on that generation. Emperor Justinian’s political calculations to hold on to power were affected by the plague, which also took a great toll on about 26 per cent of the world’s population.

Contemporary times

Recent history has had its share of the pandemics, albeit with greater sophistications in the medical sciences. After leprosy had ravaged Europe throughout the 11th century, it was followed by the infamous Black Death of the 14th century, which remains the second and largest outbreak of the bubonic plague and claimed the lives of 30 to 60 per cent of the European population. In 1665, the bubonic plague appeared again, causing the death of 20 per cent of London’s population.

With the advent of the 20th century, influenza pandemics became recurrent. Between 1889 and 1890, 360,000 died from the Russian Flu. This figure was minimal, compared to the 50 million deaths that resulted from the Spanish Flu pandemic that began in 1918.

The 1918 pandemic was shortly followed by the Asian Flu pandemic that saw two waves in the 1950s. The final pandemic of the 20th century was the human immunodeficiency virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) pandemic, which was first identified in 1981. The spread of HIV/AIDS is still considered to be a pandemic, as more than 32 million lives have been lost to this disease over the past four decades.

Jolts and lessons

The most recent pandemics are the 2003 severe acute respiratory syndrome (SARS) pandemic and the current COVID-19 pandemic which have been caused by the coronavirus. The SARS pandemic killed 774 people before it was put in check through effective quarantine efforts.  For global health agencies, the SARS pandemic was as a wake-up call which revealed the world’s unpreparedness to deal with and prevent the spread of emergent infectious diseases which have the propensity to develop into pandemics.

There were suggestions that the lessons learned in the SARS pandemic were deployed in the management and control of the H1N1, Ebola, and Zika outbreaks. Surprisingly, despite this suggestion, the world was caught napping and unprepared for COVID-19, going by its declaration as a global pandemic by the World Health Organisation on 11 March, 2020.

More than 4.13 million deaths have been attributed to COVID-19, with over 192 million confirmed cases, as of 22 July, 2021.  Apart from the loss of lives and number of cases, COVID-19 shattered the economic fortunes of the world and created a form of social restriction that made normal human interaction a taboo. It has also impacted negatively on mental health, food security and the global population.

The COVID-19 pandemic also taught the whole world great lessons on how to prepare for future emergencies, as many scientists warn of their inevitability in the future. There is the likelihood that the strategies that have been implemented to curb the spread of COVID-19 will remain in place to continue to protect the world from the spread of infectious diseases in the future.

Stakeholders Task Community Pharmacists on Evolving Pharmacy Practice

0

— As Lagos ACPN holds continuing education conference

Stakeholders Task Community Pharmacists on Evolving Pharmacy Practice
Pharm. Lawrence Ekhator, chairman, Lagos ACPN, delivering his opening speech at the programme.

Stakeholders in the pharmaceutical industry, including Dr NAE Mohammed, registrar, Pharmacists Council of Nigeria (PCN); Pharm. Kunle Oyelana, managing director, GlaxoSmithKline Consumer Nigeria Plc; Pharm. Iyiola Gbolagade, chairman, Pharmaceutical Society of Nigeria (PSN), Lagos State Branch, have emphasised the need to scale up pharmacy practice in the face of ever-growing challenges brought about by the devastating effects of COVID-19 pandemic.

While delivering his keynote address with the theme “COVID-19 Pandemic: The Need to Evolve Pharmacy Practice”, during the Continuing Education Conference, organised by the Association of Community Pharmacists of Nigeria (ACPN), Lagos State Branch, Oyelana, noted that the need to evolve pharmacy practice with a view to repositioning the practice is important at this period than any other time.

The seasoned pharmacist, who has over 20 years of experience in the pharmaceutical industry, with more than 14 years at the managerial cadre of GSK, said that to survive, community pharmacists must be willing to acknowledge the rapidly occurring changes in healthcare delivery and accept the reality that the changes will continue, noting that the COVID-19 pandemic has been the strong catalyst for change.

According to him, when the environment changes, people are bound to change, adding that there is a need for the practitioners to evolve otherwise, they will be left behind. “There are inexorable forces changing human behaviour. Before the lockdown, only a few people were used to new technologies like zoom, virtual meetings and others, but during the COVID, everybody became used to them, so there is a need for the pharmacy profession to evolve as well.

“Change is upon us as professionals and we don’t have any other choice than to key into the vision. The COVID-19 has been the biggest agent of change in the last 100 years, so in the next six months from now, if any of you fail to change from what you are doing presently, then you are at risk. So, the only way forward and the next step is to create and imagine” he said.

 

Stakeholders Task Community Pharmacists on Evolving Pharmacy Practice
A cross-section of participants at the programme

Speaking in the same vein, Gbolagade, noted that for pharmacists to survive in today’s world, they must be willing to accept the reality that Pharmacy is evolving and that the activities and practice of yesteryears are diminishing, adding that there is a need to build on the gain of the COVID transition by developing a profitable and agile business model, and as well collaborate with other healthcare professionals.

He added further that the pandemic has brought to the fore the role of the community pharmacists as a pillar in the healthcare sector and as a frontline during the heat of COVID-19, adding that it is time to consolidate on the gains  of the pandemic and embrace capacity development. He also noted that the theme of the conference was timely, considering the wave of disruption being experienced in pharmaceutical practice, with community pharmacy considered the most affected.

Fielding questions from pressmen, Chairman, Lagos State ACPN, Pharm. Lawrence Ekhator, disclosed that the Continuing Education Conference with the theme: “COVID-19 Pandemic: The Need to Evolve Pharmacy Practice” was designed to promote professional skills, business strategy skills, and practice skills of community pharmacists, saying it would help community pharmacists to better understand current economic realities, move with the trend, and be better equipped for the coming year.

According to him, the motive for starting the programme was to constantly update members on current changes in the profession and keep them up to date. “Talking about the theme, ‘the need to evolve pharmacy practice’, and the sub-theme, ‘the effect of government policies in the current economy on pharmacy practice’ community pharmacy profession has both a practice and a business component and for one to be successful in the community pharmacy space, both aspect of the practice and business must be balanced”.

While speaking, Pharm. (Mrs) Edith Nwachukwu, who was the chairman of the occasion, noted that for pharmacists to survive in today’s world, they must be willing to accept the reality that Pharmacy is evolving and that the activities and practice of yesteryears are diminishing, adding that there is need to remain updated, better informed and be up to date in order to move with the current reality.

In its goodwill message, the Registrar, Pharmacists Council of Nigeria (PCN), Dr NAE Mohammed, who was represented by Dr (Mrs) Ukamaka Okafor, director, Lagos Zonal Office, commended the Lagos State ACPN for the choice of the theme for the programme, saying it was very much in consonance with the reality on the ground for Pharmacy.

According to the Registrar, the Continuous Education Conference programme in Lagos has been consistent over the years because of the importance that the Lagos State ACPN places on knowledge and effective service delivery.

Other dignitaries at the event include Mr Bayo Rotimi, MD/CEO, Greenwich Merchant Bank, one of the guest lecturers; Pharm. Deji Osinoiki, chairman, Board of Trustees, Lagos ACPN; Pharm. Lanre Familusi, secretary, PSN-BOF; Pharm. Bolanle Adeniran, immediate past chairman, Lagos PSN; Pharm.(Chief) Yetunde Morohundiya, vice-chairman, PSN-BOF; Pharm. Ernest Okafor, chairman, PWDAN; Pharm. Josephine Ehimen, chairman, CPC; Pharm. Olabanji Obideyi, immediate past chairman, Lagos ACPN; Pharm. Madehin Gafar Olanrewaju, national treasurer, PSN; Pharm. Tony Oyawole, among others.

 

 

Great Leadership in The Digital Age

1
Prof. Lere Baale

The objective of this series is to guide the ordinary leader to do extra little things that will help move them up into extraordinary leadership level.

According to World Economic Forum, in the digital era, we are bombarded with constantly evolving technologies, such as artificial intelligence, big data and cryptocurrencies. As a result, organisations have adapted to these rapid changes with a shift from traditional forms of leadership to redefining what leadership means today.

Digital leadership is about empowering others to lead and creating self-organised teams that optimise their day-to-day operations. Leadership is no longer hierarchical – it needs participation, involvement and contribution from everyone.

But why is digital leadership important? Today, leaders need to deal with unprecedented changes and an unpredictable and challenging future, due to the Fourth Industrial Revolution. This revolution is driven by the advent of new technologies. In such a world, leadership will play a bigger role than ever. Leaders will have to create and show the way forward amid transitions, disruptions, chaos and ambiguity.

In this chaotic world, strong leadership is more important than ever. Good leaders will need to steer their teams forward and navigate the tides in the face of these chaotic transitions.

The role of digital leaders will be prominent as they will need to steer, design and build systems that create an inclusive future for everyone. Here, we look at strategies to create leadership at all levels.

Building participation and accountability

The digital economy is driven by rapid ongoing developments. Leaders cannot take ownership of everything. A leader cannot know it all, and the top-down approach is no longer sustainable.

Leaders need to empower their teams to work with autonomy and freedom, and to take decisions. Organisations need to create leaders at all levels by building participation and accountability. They need to learn from people working on the ground, take inputs and trust them. Every member of the team should be encouraged to contribute ideas, insights and knowledge for achieving shared goals.

Leaders need to build an environment where people take ownership of things and are accountable. When people care about the tasks they are performing, and work with their heart and soul, great things are possible.

Providing visionary direction, clarity and purpose

The digital world is not about technology, but people. As our day-to-day lives are increasingly immersed in technology, it is easy to lose perspective on things that matter. Leadership needs to communicate with purpose and provide direction. Leaders need to create a compelling vision, and communicate with clarity so that everyone understands what the team is trying to achieve and why.

Great leaders have the ability to decipher complexity and present simple steps towards achieving a task. Leadership also needs to be vigilant, and to create a long-term sustainable value proposition for all stakeholders.

In this digital age it’s easy to get lost in the technological aspects of daily life. However, there is a growing need for leaders to create a compelling vision, which provides others with a perspective on things that matter. Leaders need to show their teams the goals that they are trying to achieve, and why. One characteristic of a great leader is having the skill to break down seemingly impossible, complex tasks into simple, workable steps that work towards achieving the tasks. They also need to keep a watchful eye over the progress of these steps, while delegating tasks best suited to their team members’ skills.

Furthermore, leaders need to possess a positive energy that is contagious, and inspires others to be a part of their vision – as a wise person once said, “People achieve great things when they are driven by a strong purpose, and find work meaningful. When people know the why, they figure out the how.”

Leaders need to energise everyone and inspire them with an inclusive vision. People achieve great things when they are driven by a strong purpose and find work meaningful. When people know the why, they figure out the how.

Being a good communicator and nurturing others

According to the Forbes Report, which examined the data behind leadership, there are several core traits that define an effective modern leader. One of these is providing others with encouragement and praise, which the report defines as “the most important factor in coaching – more so than technical or strategic expertise.”

The report also emphasises the crucial importance of two-way listening and communication between members, which makes everyone feel valued and a part of the team. Communication enables leaders to gain insights into how others feel. Understanding the emotions of others, including what stresses them or makes them happy, enables leaders to identify where tensions lie and how to solve them; in the long run, this promotes an increase in productivity and wellbeing amongst team members.

Empowering people to experiment, innovate and execute

The average age of an S&P company was 33 years in 1964. This was reduced to 24 years by 2016, and is expected to shrink to 12 years by 2027. There are forces of creative destruction at play, and leaders need to be on top of their game to survive and thrive.

The paradox of leadership lies in staying focused on the present, while also visualising the future and creating a roadmap to reach it. Innovation is the way to remain immune to creative destruction and disruptions. Leaders need to drive innovation and experimentation, and to continuously evolve to meet dynamic needs.

When organisations create a culture of learning, failures and experiments lead to inventions and innovations. Creating leadership at all levels provides the support required for teams to iterate their way to success.

Building employee participation on all levels

As already noted, leadership in this age is no longer hierarchical – rather, it emphasises employee empowerment and building independent teams. In the past, leaders overstretched themselves, trying to get everything done. To avoid such a scenario now, leaders need to invest time, energy and human resource which allow us to see the impact of our leadership. There is a growing importance of hiring specialists and strategists who can help you focus your resources on the proper channels, saving you both time and money.

A top-down approach is no longer effective because it makes others feel insignificant and undervalued. In contrast, leaders should empower their teams to work with as much autonomy and freedom as possible to make independent decisions within their teams. No matter how junior, every member of the team should be encouraged to contribute their unique ideas, and individual knowledge, to achieve shared goals.

Building bridges and finding solutions

Technology has shattered the barriers and reduced the distances between industries, societies and places. The world is more interconnected than ever. Leaders who understand the value of diversity, inclusion and open-mindedness can navigate the challenges of technological disruptions.

The way that traditional industries operate is undergoing rapid transformation. The rise of the sharing economy, online marketplaces and digital platforms for ride-sharing, hotel booking and peer-to-peer lending means that teams need to remain open to new opportunities on the horizon.

Leaders need understanding of various business functions, industries and technologies to conceptualise the right solutions for new situations. New industries will emerge from innovations and technological developments. It will be important for teams to be open-minded and tap into new avenues for growth outside their comfort zones.

Agile teams and quick decision-making

The speed at which you do things can be the difference between success and failure in the digital economy. Leaders need a mechanism to make their teams more agile, to deal with sudden changes and challenge the status quo.

Digital leadership requires adaptability to handle pressure and constant changes, and to take decisions with agility. The projects you’re working on can lose significance very quickly through no fault of your own. In these moments of uncertainty, experts should be trusted to resurrect things, pivot the organisation and show the way forward.

Constant evolution and reskilling

The inertia of past success can be crippling for the future. Leaders need nimbleness to adapt and equip their teams with skills for the future. Innovations and disruptive technology will have a significant bearing on workforces, processes, companies and industries.

The World Economic Forum’s 2020 Future of Jobs report suggests that, by 2025, no less than 65 per cent of all employees will require significant re-and upskilling. Of these, about 40 per cent are expected to require additional training of up to six months, while 15 per cent will require reskilling lasting 6-12 months and 10 per cent will require additional skills training of more than a year.

Digital leaders will need to address the skill gaps, prepare themselves and their teams to face the future by creating an environment of lifelong learning. With the adoption of new technology and solutions, new professions, skills and industries will emerge.

The challenges ahead

The Worlds Bank’s 2019 report, The Changing Nature of Work, contains an interesting observation: IKEA, the Swedish furniture retail giant, took 30 years after its founding in 1943 before it started expanding in Europe. It reported revenue of $42 billion after seven decades. However, the Chinese e-commerce giant Alibaba reached one million users in just two years. It accumulated more than 9 million online merchants and annual sales of $700 billion in 15 years, using digital technologies.

Disruptions in the digital world occur at a phenomenal rate. They have the power to impact the way entire industries operate. All actors, from regulators to policy-makers, governments and digital leaders, need to proactively analyse the risks involved and come up with solutions for mitigating them.

Last year, there were stories about Facebook’s security breaches, privacy policies and data sharing. Millions of users were exposed and serious concerns were raised about the soft underbelly of the digital economy. This is just the sort of issue that digital leadership needs to tackle head-on.

Leaders need to create systems that ensure transparency, a thorough audit of processes and the highest ethical standards. Dealing with personal data, privacy of individuals and corporate information requires enforcement of stringent compliance and transparency.

In a world driven by devices and technology, how you lead people will make the critical difference. Leaders in this new age need to inspire, engage and lead with optimism. Technology can play a role in reducing racial, gender and economic inequalities for vast numbers of people. By empowering others to pinpoint and solve critical problems, digital leaders will have the power to shape the future of our world.

In summary, leaders in the digital age need to address the following important issues:

* Building participation and accountability

* Providing visionary direction and clear purpose

*   Being a good communicator and nurturing others

* Empowering people to experiment, innovate and execute

*     Building employee participation on all levels

* Building bridges and finding solutions

* Building agile teams and making quick decisions

Constant evolution and reskilling

Adjustment into digital challenges ahead

The great leadership in the digital age will need to empower their teams to work with autonomy and freedom. And to take decisions, they need the power to inspire, engage and lead others with clarity and optimism; they need to focus on building their communication skills, encouraging autonomy among team members; and they need to clearly identifying their goals.

Leaders in this digital age will need to address disruption in the ecosystem with direction, volatility with vision, uncertainty with understanding, chaos with clarity, ambiguity with agility, risks with resilience, and embrace divergence instead of fighting it.

Through their ability to empower others to identify and overcome key obstacles, digital leaders can successfully alter the direction of the future of their organisations.

Omicron: What We Know And What We Don’t

0

Omicron is a variant of COVID-19 first sequenced in South Africa with cases now present in over 20 countries and on all continents.

It was named only a week ago and it will take time to understand its impact on the pandemic.

Here is a summary of what we know and what questions surround the new version of the virus.

– Where did it come from? –

We don’t know. South African epidemiologist Salim Abdool Karim says it was detected first in Botswana and then in South Africa where the announcement of the new variant was made on November 25.

On Tuesday Dutch authorities announced that six days before that on November 19 an individual had tested positive for what also turned out to be the Omicron variant.

However, the World Health Organisation said “the first known laboratory-confirmed case was identified from a specimen collected on 9 November 2021”, without specifying where.

“It has probably been circulating in South Africa for longer than we thought – since early October,” Jean-Francois Delfraissy, president of the French government’s scientific advisory board told AFP.

– Why is it “of concern”? –

The day after South Africa’s announcement the WHO named the new variant after a Greek letter, like previous versions, and classified it a variant “of concern”.

The classification is based on Omicron’s genetic characteristics and also how it seems to have behaved in the population so far.

Omicron’s unique genetic structure translates to multiple changes to the spike protein that might make it more contagious and harder to control via current vaccines – but these possibilities are so far theoretical.

Meanwhile, cases in the Gauteng province of South Africa, which includes Johannesburg, have gone up rapidly with many identified as Omicron.

Researchers across the world are looking into how contagious Omicron is, the severity of the disease it causes, and whether it is more resistant to vaccines.

The WHO has said the process will likely take weeks.

– Will it replace Delta? –

The Delta variant is currently the form of COVID-19 that is the most sequenced across the globe.

Naturally-competing variants that evolved after Delta (like lesser-known Mu and Lambda) have not managed to overtake it in the population — but the spread of Omicron in Gauteng suggests it could.

On Thursday the European Centre for Disease Control said that if the pattern in South Africa is reproduced in Europe, Omicron could make up the majority of COVID-19 cases within a few months.

However, Delta was never very present in South Africa, so a comparison with Europe is hard to draw at this stage.

Writing in the British daily The Guardian, US expert Eric Topol said it is not clear whether Omicron’s spread is because of “high transmission, like Delta, or immune evasion”. 

Immune evasion is when a virus can infect a person who has already gained immunity either from a previous infection or from vaccination.

– Is it more dangerous? –

On Sunday, a South African doctor said she had treated about 30 cases of Omicron and had only encountered “mild symptoms” in these patients.

The scientific community warned against drawing conclusions based on this testimony since the patients were mostly young and therefore less at risk of serious COVID-19.

So far, all cases detected in Europe are “either asymptomatic or with mild symptoms”, according to the EDCD.

This does not mean that Omicron will not cause serious Covid – but it does leave the door open to a rare optimistic hypothesis.

“If Omicron is very contagious but doesn’t cause severe Covid (and doesn’t fill hospital beds), it could confer group immunity and contribute to making SARS-CoV-2 into a benign seasonal virus, which would help end the crisis,” French virologist Bruno Canard tweeted.

He added, however, that such a scenario would be a “stroke of luck”.

– What about vaccines ? –

Again, it is too early to say whether vaccines will be less effective against transmission or severe disease from Omicron than against other variants.

“We have to see whether the antibodies produced by current vaccines still work and to what extent – whether they still prevent severe illness,” said Enouf.

While waiting for real-world data, scientists are trying to answer this question through lab tests.

But even if vaccines are less effective against Omicron it doesn’t mean they will be totally ineffective.

In addition to the antibody response that could be weakened by mutations in Omicron, the body has secondary T-cell responses that can protect against severe illness.

“We think that the cell response will be partly effective against Omicron,” said Delfraissy.

(AFP)

Pfizer Foundation Donates $6.4 Million to Fight Infectious Diseases

1

 

Pfizer Empowers Patients against Breast Cancer , Harps on Early Detection
Pfizer logo

Poised to rid the West African coast of infectious diseases, the Pfizer Foundation has donated $6.4 million in grants to address critical infectious disease challenges in Nigeria and Ghana, as part of a long-term commitment to help protect underserved people in the United States of America and around the world.

The Pfizer Foundation is a charitable organisation established by Pfizer Incorporations to promote access to quality healthcare, nurture innovation, and to support the community involvement of Pfizer colleagues.

According to the President of The Pfizer Foundation, Caroline Roan, grants to CARE, International Rescue Committee (IRC) and PATH will support programmes to reduce childhood mortality, improve maternal health and address the growing threat of antimicrobial resistance (AMR) in the region.

Roan, who also doubles as senior vice president, Global Health & Social Impact, Pfizer Incorporations said “The global pandemic has magnified the disproportionate burden of infectious diseases, particularly in resource-limited settings where people have inadequate access to essential health services.

“We are proud to support the critical work of our partners in West Africa as they create localised approaches to bring quality health services to the community level and address persistent inequities in infectious disease prevention, diagnosis and treatment”.

Global Infectious Disease Burden

Roan disclosed that globally, nearly 8 million people lose their lives each year from infectious diseases that could be avoided with access to basic healthcare, often in the most underserved communities.

She further revealed that out of those lives lost, more than 2 million are among children under-five, almost half of which take place in West Africa.  “Additionally, the growing risk of AMR is already having a profound impact on people today and, if left unchecked, by 2050 could lead to 10 million deaths from resistant infections each year”.

 

Laudable Efforts of Infectious Disease Impact Initiative

Through the Infectious Disease Impact Initiative, The Pfizer Foundation has been partnering to create sustainable solutions that help strengthen healthcare systems in West Africa and around the world.

First among the organisation’s project is tagged “CARE”, which is targeted at reducing  under-five mortality through a community-based care model that delivers a core package of quality child health services and enhances community-based surveillance to improve the detection of infectious diseases in Nigerian Yobe State

 

The IRC, is another project, which developed a functional and effective AMR stewardship programme within health facilities, aimed at reducing child mortality, in northeast Nigeria’s Borno State. The programme serves as a model for other humanitarian health programmes, where crisis has contributed to a growing number of drug dispensaries with undertrained staff and knowledge gaps at the community level.

 

 PATH is the third project, according to the organisation, and it aims at reducing newborn morbidity and mortality in Ghana by improving diagnosis and management of maternal infections, through the integration of point-of-care diagnostics and community-based screenings of infectious diseases as part of antenatal care.

Speaking on the Foundation’s initiative in combating diseases, Country Manager and Cluster Lead West Africa, Pfizer Inc, Pharm. Olayinka Subair, said: “Consistent with our responsibility to deliver breakthrough medicines and vaccines into patients’ hands across the world, we collaborate with healthcare providers, governments, and local communities to support and expand access to reliable, affordable health care,” said. “We work every day to provide access to global scientific innovation that can help patients to live longer, healthier lives”.

Roan, also made mentioned of the recent award The Foundation presented to the 2021 recipients of the Global Health Innovation Grants (GHIG) programme – including non-governmental organisations (NGOs), non-profits and social enterprises in low- and middle-income countries – to support community-based initiatives focused on combatting infectious diseases.

She noted that four of the 20 organisations in this year’s cohort have programmes based in West Africa, including Equitable Health Access Initiative, Last Mile Health, Muso and THINKMD, which will each receive $100,000 as part of the annual programme.

 

Get Your Pharmanews App on Android Now

2
For those who are yet to get the mobile version of Pharmanews, this is to inform you that
Pharmanews, Nigeria’s Leading Health Journal recently launched its mobile Android applications on Google Play Store.

Pharmanews App and Pharmanews PDF App are now available for download on Google Play Store. To enjoy this added values from Pharmanews, click the links below to download them on your mobile devices.

Pharmanews App

https://play.google.com/store/apps/details…

Pharmanews PDF App

https://play.google.com/store/apps/details…

What are you waiting for?

Start downloading now!

NANNM Laments Exodus of Over 6000 Nurses from Nigeria

1

-Tasks FG on better working conditions for nurses

NANNM Laments Exodus of Over 6000 Nurses from Nigeria
NANNM President, Com. Michael E. Nnachi

The National Association of Nigerian Nurses and Midwives (NANNM) has decried the migration of over 6000 nurses and midwives from the shores of the country, saying if no urgent steps are taken by the government to stem the tide of brain drain in the healthcare workforce, the country’s healthcare delivery system will continue to experience setbacks.

The association therefore urged the government to scale up the remuneration of nurses, as well create conducive and safe environment for them to operate, noting that studies have shown that a healthy work environment can lead to more engaged nurses, decreased burnout, lower turnover and better patient care.

Speaking in an interview with Pharmanews, the NANNM President, Com. Michael E. Nnachi, stated that there are proofs that nurses and midwives in the country work in very difficult environments and are poorly remunerated. This, he said, exposes them to numerous diseases and ill-treatment, victimisation, violent attacks and kidnapping experiences.

He further bemoaned what he considers to be excessive workload of Nigerian nurses, stressing that standard nursing practice ethics stipulate a nurse-patient ratio of one to four, whereas an average nurse in the country is in charge of 16 patients, or in some cases 25 patients.

“At times, there will be one nurse taking care of all the patients in a 20-bed ward. So, there is no way the best professional care can be given to patients because you need to monitor them to make sure things are going well as expected. If you don’t monitor, you will not know that things are going wrong with the patients,” he noted.

The NANNM president further highlighted key areas of nursing practice to be addressed by the government to improve the working conditions and boost the efficiency of nurses in the country.

According to him, these include: “Proper placement of nurse graduates and interns (in the scheme of service); improved salary package (special nurses salary structure); upward review of professional allowances (shift duty, teaching allowance, call duty, specialty allowance for midwives/ other specialty nurses); payment of desirable hazard allowance for being most exposed to diseases/hazards; provision of safe working environment; payment of any outstanding allowances/ benefits; payment of uniform allowance; employment of more nurses and midwives to reflect WHO provided nurse-patients ratio.”

Stressing that nurses need the best conditions of service and should have priority attention by the Nigerian government, Nnachi noted that the ideal work environment for nurses is one in which there is enough staff on duty to assist all of the patients and meet their needs quickly.

In his words, “Healthier work environments lead to more satisfied nurses which will result in better job performance and high quality of patient care, which will subsequently improve healthcare organisation financial ability.

“For effective and efficient healthcare delivery, the nurses need to work in a decent environment where there is adequate staff, safety, adequate remuneration, available functional tools, less stress, suitable protective device, etc., which will provide the nurses and midwives the opportunity to effectively deliver the best of patient outcomes. The situation is in the contrary, as Nigerian nurses and midwives work in a very tight corner, and highly restricted and difficult environment.

He continued: “Nurses and midwives are among the most critical and important professionals in healthcare delivery. They are the cornerstone of the healthcare system. No healthcare facility can do without the nurses and midwives. Their roles and services are indispensable to humanity.”

Nnachi, while expressing hope of government’s swift response to NANNM’s call, also appealed to nurses and midwives to continue to render compassionate and qualitative services to healthcare consumers who depend on their indispensable roles for better healthcare.

PSN 2021 Elections: Lessons in Decorum and Transparency

0
PSN 2021 Elections: Lessons in Decorum and Transparency
Conference logo

There are very good reasons why the recent elections of the Pharmaceutical Society of Nigeria (PSN) which heralded its new executive committee have continued to attract commendations from stakeholders and observers within the pharmaceutical landscape in Nigeria and beyond. The general conduct reflected such good statesmanship and camaraderie that reinforce the fact that pharmacists, as men of honour, will always join hands in the pursuit and preservation of the lofty ideals democracy, good governance and collective progress.

The immediate past President of the apex pharmaceutical body in Nigeria, Mazi Sam Ohuabunwa, had during the Gala and Award Night that signalled the end of the just concluded 95th annual conference of the Society in Port Harcourt, stated that the PSN is a body worthy of emulation, going by the peaceful and transparent way it handled the elections. According to him, even the Nigerian government can learn a few lessons from the Society in conducting credible elections.

We agree with him. All through the electioneering process, till the time the votes were cast, there were no cases of rancour, campaigns of calumny, inducement of voters or any other unbecoming conduct. Beyond Mazi’s encouraging remarks, however, we believe that pharmacists, by their profound training, constructive comportments as well as notable antecedents in public office, have a lot to offer the Nigerian state, in building lasting institutions that will guarantee a stable, safe and prosperous society.

Right from the presidential debate organised by Pharmanews and the PSN for the candidates to acquaint the public with their manifestoes and, perhaps, leadership philosophies, the spirit of selflessness and understanding that the four candidates exhibited showed that their individual ambitions were for the greater good of the pharmaceutical family in Nigeria. The passion and commitment that the candidates put into their individual campaigns also typified the unflinching belief they have in the instrumentality of the PSN’s pride of place in offering the right leadership to the Nigerian health sector.

However, it must be noted that the quantum of time, money and other resources channelled into the campaign processes was superfluous. This could discourage potential candidates in future elections, who might not have the wherewithal for such ostentation. The PSN should find a way to institutionalise the philosophy of moderation in campaign spending, in order to encourage more pharmacists to aspire to its leadership positions.

Moreover, as it had been for almost every other election in the history of the Society, there was no female among the last election candidates. It is our view that, as a progressive Society that is abreast of universal best practice and has competent and qualified professionals of both genders, the PSN should encourage gender balance in its internal politics by encouraging more women to aspire to its highest office. It is bewildering that, since the inception of the Society in 1947, only one woman – Pharm. (Lady) Eme Ufot Ekaette – has emerged president (1997-2000). We expect a change of narrative in the subsequent elections.

As we join all Nigerian pharmacists to congratulate Professor Usifoh on his momentous victory, we call on the three other candidates to sustain their exemplary spirit of comradeship by supporting the new leadership with their wealth of experience and expertise. More importantly, we urge the new president to strategically begin to implement his campaign promises.

There is no doubt that Mazi Ohuabunwa recorded a number of notable achievements while in office. Efforts must be made to sustain and build on these to take the pharmacy profession to greater heights. Additionally, Prof. Usifoh must make good his promise of building a united and progressive pharmacy family, where pharmacists are increasingly relevant, respected and adequately remunerated for their invaluable contributions; as well as networking with other members of the healthcare team and other professionals for the growth and development of the pharmacy profession in Nigeria.

Moreover, the president must marshal his executive team and other relevant stakeholders towards getting assent to the Pharmacy Bill, institutionalising the PharmD  programme across pharmacy schools, actualising the consultant cadre agenda, resolving the chaotic drug distribution debacle, strengthening relationships with NAFDAC, PCN and other relevant stakeholders, improving the visibility of pharmacists, advancing the Pharmacy Tower project and all other business concerns of PSN, as well as providing purpose-driven leadership for all technical and interest groups of the Society.

The main principle of shock treatment is:

7

The main principle of shock treatment is:

a) To increase the arterial pressure

b) To increase the peripheral vascular resistance

c) To increase the cardiac output

d) To improve the peripheral blood flow

Kwara State Government Moves To Resolve Nurses Strike

0

The Kwara State Government has waded into the strike action embarked upon by the state chapter of the National Association of Nigeria Nurses and Midwives, in state government-owned hospitals.

Recall that the members of the association are on strike to press home their demands for better welfare, safety at the workplace, shortage of personnel in hospitals, and disparity in remuneration of nurses at state and local government levels.

Kwara govt moves to resolve nurses’ strike

At a meeting on Monday night between Governor Abdulrahman Abdulrazaq and officials of the association led by the chairman, Comrade Aminu Sheu, the governor assured that the issues would be resolved amicably by the government.

Comrade Aminu, in a telephone chat with DAILY POST in Ilorin on Wednesday, appreciated the proactive steps of the governor saying he is convinced that a positive response will come from the government very soon.

He, however, appealed to the members of the association to be patient and return to work while awaiting government action on their grievances.

The chairman explained that “it is important they go back to work while negotiation with government is currently ongoing.”

In a plea message to the members, the leadership said, “We understand your pains and what you are all passing through, but please, we want to assure you that we are not relenting on our efforts.

“Let us just be guided appropriately and follow due process. We didn’t call off the strike, we only suspended it for the while.

“We are working towards our demands and when they are not met, we can go ahead with the strike.”

Reacting, the state Commissioner for Health, Dr. Raji Razaq, confirmed the development.

He said, “they are demanding for salary increment and the government is working on it very soon, they will smile home.”

The association had transmitted the letter of a 7-day warning strike to the authorities to look into their grievances or risk a full-blown strike action in hospitals owned by the state government in the 16 local governments of the state.

Efforts to reach the DG, State Hospital Management Bureau, Mr Aluko, did not yield results.

When contacted on phone, he said he was attending a meeting and promised to call back but was yet to do so at the time of writing this report.

Their grievances include, among others, implementation of 100 percent 2019 enhanced CONEHSS, provision of security in hospitals to prevent reoccurrence of assault on members at their workplace, and poor welfare.

Others include disparity in remuneration of staff at local and state government level, with state workers taking 60 percent while local workers taking 50 percent, shortage of manpower in the state hospitals, and implementation of promotion of members as promised by the authorities

US Announces First Omicron Case in Traveller Returning From South Africa

0

The United States on Wednesday announced its first confirmed case of the COVID-19 Omicron variant had been detected in California, in a fully vaccinated traveller who had recently returned from South Africa and was recovering from mild symptoms.

Top health official Anthony Fauci said authorities “knew it was just a matter of time” before the strain was found in the country, reminding Americans that vaccination, boosters and masking in indoor public settings remained the best way to stay protected.

According to a statement by the Centers for Disease Control and Prevention, the person returned from South Africa on November 22, and their close contacts have all tested negative.

Speaking to reporters, Fauci added that the patient tested positive on November 29 and that they had not received a booster, to the best of his knowledge.

Some early press reports regarding the Omicron variant have suggested it might confer more mild illness, but Fauci cautioned reading too much into these until more hard data was available. 

“We feel good that this patient not only had mild symptoms but actually the symptoms appear to be improving,” he said.

“But as we said, there’s a lot of information that is now evolving out of countries like South Africa that have a much larger number of individuals” with the variant, he added.

Such data should follow in the coming weeks and months. 

While the person involved was fully vaccinated, Fauci stressed a Covid booster remained a good idea because it raises the number of overall antibodies in a person’s immune system, some of which will remain effective at stopping new variants.

“Our experience with variants such as the Delta variant is that even though the vaccine isn’t specifically targeted to the Delta variant when you get a high enough level of an immune response, you get spillover protection,” he said.

Fauci also defended the travel ban the US had placed on southern African countries, which UN Chief, Antonio Guterres has slammed as “unfair” and “ineffective.”

“We needed to buy some time to be able to prepare, understand what’s going on,” he said.

“We wanted to make sure that we didn’t all of a sudden say it’s like anything else, don’t worry about it, and then all of a sudden, something unfolds in front of you that you’re really not prepared for. So we look at this as a temporary measure.”

To prepare for Omicron, the US is planning tougher testing and weighing quarantine requirements for international travelers arriving in the country, including taking a COVID-19 test one day prior to departure, the CDC said Wednesday.

(AFP)

World AIDS Day 2021 – WHO Urges Govts to Prioritize Investment in Health

0

As Nigerians join the rest of the global community to mark the 2021 World AIDS Day, which is celebrated on every 1 December, the World Health Organisation (WHO) Regional Director for Africa, Dr Matshidiso Moeti,  has called governments to prioritize investment in health funding for community-led, human rights-based, and gender transformative responses.

The theme of this year’s World AIDS’ Day, “End inequalities. End AIDS. End pandemic” has particular resonance nearly two years into the COVID-19 pandemic. Noting that global solidarity and shared responsibility are critical components of the kind of rights-based approach we need if we are to end HIV/AIDS and COVID-19.

Dr Moeti said:  “We cannot adequately express our support for those living with HIV, especially within a context where we know that treatment and care have been negatively impacted across Africa by the demands of COVID-19. As we remember those who have lost their lives to AIDS this year, we also acknowledge the terrible death toll the Corona virus pandemic has taken and continues to take.

“Going forward, we cannot afford to lose focus on the urgent need to end the inequities that drive AIDS and other epidemics around the world. It has been 40 years since the first HIV cases were reported. Yet, in Africa and globally, it remains a major public health concern.

“Last year, two out of every three new HIV infections occurred in the African Region, corresponding to almost 2 500 new HIV infections every day. Sadly, AIDS claimed the lives of 460 000 people, or a shocking 1 300 every day, in spite of free access to effective treatment.

“The challenges notwithstanding, Africa has made significant progress against HIV in the past decade, reducing new infections by 43 per cent and nearly halving AIDS-related deaths. In the region, 86 per cent of people living with HIV know their status, and 76 per cent are receiving antiretroviral therapy”.

The Regional Director for Africa in his speech salutes Botswana, which is on the home stretch to eliminating mother-to-child HIV transmission in what is a truly remarkable public health success. He added that only 16 countries have been certified for eliminating mother-to-child HIV transmission, none of which had as large an epidemic.

He also noted that it has taken more than two decades of hard work by leaders, health workers and communities, illustrating what are possible when the health and welfare of mothers and children are prioritized.

“The continent as a whole is, however, unlikely to end AIDS as a public health threat by 2030, after we fell short of the expected 75 per cent reduction in new HIV infections and 81 per cent reduction in AIDS-related deaths by 2020. Despite the very high percentages of people living with HIV who know their status, and treatment rates, new HIV infections and AIDS-related deaths are not decreasing concomitantly.

“It remains critical for us to reach those who are fuelling the epidemic, addressing the persistent inequities in the provision of quality care and interventions. For instance, in West and Central Africa last “year, key populations and their sexual partners accounted for 72 per cent of new adult HIV infections. Yet punitive laws, policies, hostile social and cultural environments, and stigma and discrimination, including in the health sector, prevent them from accessing services, he explained”.

While narrating some stories about Sub-Saharan Africa, he said young women are twice more likely to be living with HIV than men. Noting that for adolescents aged 15 to19 years, three in every five new infections are among girls who don’t have access to comprehensive sexuality education, who face sexual and gender-based violence, and live with harmful gender norms. They also have less access to school than their male peers.

He said with COVID-19, people living with HIV appear to be at elevated risk for virus-related illness and death as nearly 70 per cent live in the WHO African Region, where only 4.5 per cent of people are fully vaccinated against COVID-19.

“We must ensure that everyone, everywhere, has equal access to HIV prevention, testing, treatment, and care, including COVID-19 vaccinations and services,” Moeti advised.

Which stage of sleep is responsible for the incidence of dreams?

5

Which stage of sleep is responsible for the incidence of dreams?

a) REM sleep

b) Slow wave sleep

c) Stage 2NREM sleep

d) All of the above

Our Personality For the Month is Pharm. Lawrence Ekhator

0
Pharm. Lawrence Ekhator

Pharmacist Lawrence Osaretin Ekhator, current chairman of the Association of Community Pharmacists of Nigeria (ACPN), Lagos State Branch, was born into the family of Mr Robert Ighitu Ekhator and Mrs Rachael Amen Ekhator on 26 November 1973 in Lagos. He is an  indigene of Uhunmwonde Local Government Area of Edo State.

Ekhator attended International Women Society (IWS) Day Nursery School, from 1976 to 1978; then Corona School, Gbagada, from 1978 to 1984. He had a brief stint at Igbobi College, Yaba, from 1984 to 1985, after which he proceeded to the Federal Government College, Warri, from 1985 to 1990.

He soon gained admission to study Pharmacy at the University of Benin (UNIBEN) in 1992 and obtained his B.Pharm in 1997. He also obtained a master’s degree in Clinical Pharmacy and Biopharmacy from the University of Lagos, in 2002.

Ekhator had his internship at the renowned Commercial Medicines Stores, Yaba and Lagos Island, where his interest in community practice was kindled. Thereafter, he proceeded to observe his mandatory one year National Youth Service at the General Hospital, Offa, in Kwara State.

He started his career as a fully licensed pharmacist as a medical representative with Wyeth/Delpitano Pharmaceuticals from 2000 to 2007. He was involved in the marketing of the Wyeth range of pharmaceuticals and the nutrition segment of the company. Wyeth Nutrition, being operated then by I-Japt International Company Limited, was the sole marketer of the SMA range of infant formula and was actively involved in the introduction and marketing of SMA Progress into the Nigerian market, as the number one follow up milk for weaning infants.

He also had a stint as product manager with Mega Lifesciences and Royale Resources Limited, before moving fully into community practice in 2008. He has been the superintendent pharmacist of Robson Pharmaceuticals Limited, in Bariga, Lagos State, since then.

Ekhator is an active member of the Pharmaceutical Society of Nigeria (PSN) and the Association of Community Pharmacists of Nigeria (ACPN), as well as other professional bodies.

He is also a pharmaceutical inspector of the Pharmacists Council of Nigeria (PCN) and has served in various capacities at the zonal, state and national levels of the ACPN. He was a secretary of the Gbagada Zone of the ACPN, before becoming state assistant secretary, then secretary and vice-chairman and then national assistant secretary.

He has also served in various committees of the ACPN and PSN at various times.

Ekhator, a merit award winner of the Lagos State PSN is happily married to Mrs Blessing Ekhator and the marriage is blessed with children.

Nigeria Confirms Three Omicron Cases in Passengers From South Africa

0
Nigeria Confirms Three Omicron Cases in Passengers From South Africa
Nigeria Confirms Three Omicron Cases in Passengers From South Africa

The Nigeria Centre for Disease Control (NCDC), on Wednesday morning confirmed the first case of the Omicron variant in the country.

This is contained in a press release issued by the centre and signed by the Director-General, Dr Ifedayo Adetifa and made available to News Agency of Nigeria (NAN), Abuja.

NAN reports that the new variant has sparked global concerns due to fears it may spread faster and be resistant to vaccines.

Following its discovery in South Africa, Omicron was first detected in Europe in Belgium on Nov. 27, 2021.

Other European countries, including Germany, Italy and the U.K., have confirmed cases. Australia also reported cases on Nov. 28, 2021.

The European Union on Nov. 27, 2021, moved to ban travel from seven Southern African countries.

Other nations, including the U.S. and U.K., are adopting similar moves. Israel late Saturday went further, imposing a two week travel band for all non-residents.

Similarly, the government of Canada had also stated that it discovered two cases of the variant from two passengers from Nigeria.

The Federal Government through the Presidential Steering Committee (PSC) on COVID-19, however, said that it was investigating the issue to get more details.

Adetifa , however, on Wednesday morning said two cases of the variant were discovered through genomic sequencing.

It albeit linked the cases to two passengers from South Africa.

“In line with the routine travel tests required of all international travellers, genomic sequencing at the NCDC through its National Reference Laboratory, Abuja, confirms Nigeria’s first case of the Omicron variant.

“Genomic sequencing of positive cases from routine day-two testing for travellers to Nigeria identified two cases of Omicron variant among travellers from South Africa who arrived in Nigeria past weeks.

“Retrospective sequencing of previously confirmed cases among travellers to Nigeria also identified the Omicron variant among samples collected in the past weeks 2021,” he explained.

He added that the three patients were asymptomatic and contact tracing had began.

NAN recalls that Genomic sequencing analyses the virus sample taken from a diagnosed patient and compares it with other cases.

By the time the virus arrived in Nigeria, the different changes, or mutations, of COVID-19 “define branches on a tree”.

Each branch of COVID-19 that exists in Nigeria could be linked back to the South Africa, China, UK in the original instance, as well as via an outbreak in a foreign country.

The new variant is coming at a time Nigerians have let down non-pharmaceutical measures like face and nose masking, hand washing and social distancing.

It is also coming at a time when aside border surveillance, Nigeria seems to have developed cold feet in her in-country responses like surveillance and community testing.

With the lull in these activities, the new variant may have had its way into Nigerian communities already and so the need to spring back to action has just been reiterated especially now that the festive season is here. (NAN)

Subair Reveals Why Pfizer Is Committed to Bridging Affordability Gap

0

 

 

Subair Reveals Why Pfizer Is Committed to Bridging Affordability Gap
Pfizer logo

Pharm. Olayinka Subair, Pfizer country manager and cluster lead West Africa, has disclosed reason for Pfizer’s commitment in closing affordability gap to quality healthcare, which is to improve patients’ lives through provision of access to innovative healthcare products.

He noted that being a patient-focused pharmaceutical multinational, Pfizer has been consistent for over 170 years in collaborating with healthcare providers, governments, and local communities to support and expand access to reliable, affordable healthcare around the world for patients best outcomes.

In a statement made available to Pharmanewsonline, Subair hinted on the various efforts of the pharma giant in bringing sound healthcare closer to the people in their communities.

According to him :”Applying our science and global resources to bring therapies to patients in a way that extends and significantly improves their lives is what we strive for as we set the standard for quality, safety and value in the discovery, development, and manufacture of healthcare products, including innovative medicines and vaccines.

“Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

“Guided by our three pillars of innovation, investing and safeguarding, we constantly focus on serving the communities in which we live and work, broadening access to medicines and strengthening healthcare delivery for the people who need it most.

“To close the patient affordability gap and increase patient access to much needed oncology treatments, we partnered with the American Cancer Society and the Clinton Health Access Initiative (CHAI) on a groundbreaking market access agreement for access to cancer treatments. The aim is to reduce the price of 16 priority and quality-assured medicines by almost 50 percent in six countries in Africa. Since the launch of the program in 2019, several patients have accessed life-saving chemotherapy treatment”, he revealed.

In tackling the challenges of healthcare financing and access, the Pfizer Country Manager, said “Our Project Taksit, a novel payment program (in partnership with mPharma) enables patients to pay via instalments. Project Taksit is providing patients with immediate access to their medication while enabling them to pay over 30 days with majority of the enrollees being patients paying out of pocket and insured patients whose plan is not covering the full length of hospital stay. The program is running in more than 20 Hospitals with plans to scale up”.

He further mentioned another programme launched by Pfizer- Project Afya, a patient assistance programme aimed at improving access to life-saving medications and boosting cancer care and autoimmune disease management. Project Afya is supporting patients suffering from two disease areas namely oncology (specifically breast cancer) and rheumatoid arthritis in low income urban and rural areas. In partnership with IQVIA, the platform is helping to reduce therapy costs for eligible patients with the support of government’s health insurance in collaboration with key partners such as NGOs and charities.

Subair averred that Project Afya is particularly significant for a country such as Nigeria where research shows that breast cancer accounts for 16.4% of the cancer mortality rate, followed by cervical cancer (12%) and prostate cancer (11%) and autoimmune diseases such as rheumatoid is a significant medical condition in Nigeria, affecting mostly women. Project Afya is aimed at alleviating some of the pressure on the country’s already over-burdened healthcare system, where large numbers of people need greater access to specialized medicines. Addressing this healthcare gap will go a long way towards improving treatment outcomes.

He continued, saying Pfizer has commissioned health information technology and clinical research company, IQVIA, to implement the programme throughout Nigeria in partnership with NGO’s and charities. The programme is made up of four prongs: referral, enrolment, eligibility assessment and improved access.

“The process will see healthcare providers introducing and referring patients to the programme. Patients will then contact IQVIA to book an appointment and present relevant information. IQVIA will then assess them and offer a discounted payment scheme based on their annual income. Patients will then be issued with unique voucher cards to enable them access their medication from pharmacies”, he explained.

 

 

 

African Genes Could Have Weakened COVID-19 Virus in New “Omicron” Variant, Says Obaje

0
African Genes Could Have Weakened COVID-19 Virus in New “Omicron” Variant, Says Obaje
African Genes Could Have Weakened COVID-19 Virus in New “Omicron” Variant, Says Obaje

Dr Jonathan Obaje, a Nigerian Research Scientist based in Singapore, says based on preliminary clinical data coming from South Africa on the “Omicron” variant of the COVID-19 virus, African innate immunities may have already weakened COVID-19 virus significantly.

Obaje, a former Vice President of Nigeria in Diaspora, Singapore, said this on Tuesday in a telephone interview with the News Agency of Nigeria (NAN).
He quoted various media reports across South Africa, saying Hospitals across the country reported that symptoms of “Omicron”, the new COVID strain, are very mild and no record of death associated with it so far.
“Around 90 per cent of all new infections in Johannesburg region are now caused by Omicron, so far, COVID death rate and even hospital admissions appear not to be increasing significantly.
“Some medical and scientific researchers worldwide are currently talking about this and are cautiously optimistic that if Omicron turns out to be less-lethal, but more contagious and dominant than the Delta variant, the new mutation may actually be a blessing in the sky.
“This is exciting news; African innate immunity may have weakened COVID-19 virus. The world should be grateful to the African gene for ending COVID-19 pandemic.
“The fact that Africa has had least COVID-19 vaccination, yet recorded lowest fatalities, with many COVID-19 infections but high recovery records, points science to take a closer look of the African phenomenon”.
He noted that since 2019, Africans innate immunity may have dealt with COVID-19 virus silently, with 32 mutations of the spike proteins, without the watchful eyes of the world.
He, however, said that the weakened variant of COVID-19 virus coming out of Africa could mean the end of the pandemic, saying such could be the best Christmas gift ever from Africa to the world, which has left Africa largely unvaccinated. (NAN)

BREAKING: Nigeria Records First Case of Omicron COVID-19

1
Ifedayo Adetifa Becomes New NCDC Director General
Dr Ifedayo Adetifa

The Nigeria Centre for Disease Control (NCDC) says Nigeria has confirmed her first two cases of Omicron variant of the novel Corona Virus in the country among South African travelers, who came into Nigeria last week.

In a press release announcing the development, the NCDC Director General, Dr Ifedayo Adetifa, disclosed that the agency confirmed two cases of Omicron, also known as B.1.1.529 lineag, through routine travel test required of all international travelers and genomic sequencing at the NCDC.

He further explained that retrospective sequencing from previous samples collected in October also confirmed cases among travelers into the country.

He said: “Genomic sequencing of positive cases from routine day- two test for all travelers to Nigeria identified two cases of Omicron variant among travelers from South Africa who arrived in Nigeria in the last week.

“Retrospective sequencing of the previously confirmed cases among travelers to Nigeria also identified the Omicron variant among the sample collected in October 2021”, he stated.

Adetifa, also mentioned that the two recent cases were linked to clinical care and other activities, as the agency has commenced contact tracing and has also contacted the country of the affected persons for proper contact tracing to begin.

Prof. Femi-Oyewo Hands Over to Adagadzu, Lists BOF’s Achievements

0

 

Prof. Femi-Oyewo Hands Over to Adagadzu, Lists BOF’s Achievement
Immediate Past Chairman, BOF, Prof. (Mrs) Mbang N.Femi-Oyewo, exchanging a handshake with the new chairman, Pharm.(Dr) Joel Adagadzu, shortly after handing over insignia of office.

The Immediate Past Chairman (IPC), Board of Fellows (BOF) of the Pharmaceutical Society of Nigeria (PSN), Prof. (Mrs) Mbang N. Femi-Oyewo, has officially handed over insignia of office to the newly elected BOF Chairman, Pharm. (Dr) Joel Adagadzu, on Monday at the BOF Secretariat, Anthony, Lagos, as she highlighted the achievements of the Board under her watch.

The handover ceremony, which was graced by other executives of the Board, also witnessed the handing over of the Immediate Past Treasurer, Pharm. (Chief) Chris Ibeto, to the new treasurer, Pharm. (Mrs) Ngozi Obikili.

Reminiscing on the events of the past three years, when she and her executives took over the leadership mantle of the Board, an elated Femi-Oyewo, expressed her profound gratitude to the Almighty God for His guidance and to all Fellows for the opportunity to serve in such capacity. She recalled how she promised through her manifesto to project the Board for PEARLS- an acronym which stands for P- Prestige, E-Excellence, A-Activities/Achievements, R-Relevance/Respect, L-Leadership and S-Services; which they achieved to the glory of God.

“Three years ago, I and my outgoing executives were elected to serve and also manage the affairs of the Board of Fellows. Once again, we thank the Fellows for the opportunity. The experience gained during our tenure is quite rewarding and amazing. We want to thank Almighty God for guiding us through these three years and we sincerely hope that we have put in our best and have not disappointed you”, she recounted.

 Prof. Femi-Oyewo Hands Over to Adagadzu, Lists BOF’s Achievement
L-R: Pharm.(Chief) Lanre Familusi, BOF secretary; Pharm.(Mrs) Edith Nwachukwu, BOF financial secretary; Prof.(Mrs) Mbang N.Femi-Oyewo; IPC, BOF; Pharm. (Dr) Joel Adagadzu; BOF chairman; Pharm.(Chief) Yetunde Morohundiya, BOF vice-chairman; Pharm.(Mrs) Ngozi Obikili, BOF treasurer and Pharm.(Chief) Chris Ibeto, BOF unofficial member, in a group photograph at the handover ceremony, on Monday.

Some of the milestones of the BOF during her leadership were listed as follows: Investment in form of N10M debenture in PSN – Pharmacy Tower project; procurement of Innoson- 15-seater bus for the BOF Campaign against Drug Abuse at N19, 188,750; Fellows Insurance Scheme; Acquisition of a property – apartment in Queens Court, Yaba, Lagos, to generate fund for the Board; Construction of a functional website for the Board; Creation of mentorship platform;  Introduction of public lectures 2019 -2021; Awarded N1m BOF 2021 Research Grant  to Pharm. (Mrs.) U. I. Olayemi and donation of drugs, consumables and food items worth N1M to Rehabilitation Centre in Lagos State.

The IPC, BOF, also mentioned some of the publications made during her tenure including BOF Directory, 2019; BOF Lecture Series Volume 2 and 3 with communiques. “During my tenure the dinner lectures were replaced by BOF Public Lectures- a great innovation that showcased BOF in the limelight. The website is fully uploaded and we are very visible on the net – www.bofpsn.com” she stated.

Prof. Femi-Oyewo, particularly emphasised payment of two annual dues for new Fellows of 2021 and endowment fee of N25,000, while urging all indebted Fellows to pay up their accumulated dues, as the Board has huge amount of money hanging outside.

According to her “The Board has requested that new Fellows should be asked to pay two years annual dues (N60,000) and endowment fee (N25,000), resulting in N85,000 each. Thus expected income from new Fellows (112) is N9,520,000. Please ensure this is done.

“I am grateful to our State/ Zonal Coordinators for their commitment and finally, I want to thank the members of my former and current (outgoing) executives for the wonderful cooperation they have given me, the dedication and loyalty with which they pursued their assignments. Thank you my IPC Pharm (Barr) Chiedu Mordi, FPSN, and President PSN, Pharm (Mazi) Sam Ohuabunwa, FPSN and Past BOF Chairmen.  To our Admin Officer Mrs Vivian Iwuamadi- l thank you on behalf of past chairmen and BOF.

“Indeed- We came, we saw, we conquered, just like David did with the Lord. By asking “Should I pursue, will I overtake, will I recover all?  And the Lord prospered their course”. The Lord has indeed prospered our course, our BOF. We are like them that dreamed. He will continue to prosper us in Jesus Mighty Name. Amen”.

The new BOF Chairman, Adagadzu, assured all Fellows of the readiness of his executives to hit the ground running,  notwithstanding the enormity of the workload, said with experienced team members and support of all past chairmen, they are sure of a successful tenure.

He appreciated the IPC for achieving so much in a very difficult period, as he requested for her wise counsel to the new executives.

Adagadzu, a former senatorial aspirant under the People’s Democratic Party (PDP) expressed his delight in being surrounded by colleagues he had worked with for many years, especially the Vice-Chairman, Pharm.(Chief) Yetunde Morohundiya, who was his classmate.

“We may not change for the sake of changing, but for the benefit of BOF”, he stated.

 

 

 

 

 

COVID-19 Vaccination: NPHCDA Lists Ogun, Nasarawa, Oyo as Best Performing States

0

The National Primary Health Care Development Agency says the states of Ogun, Nasarawa, Oyo, Osun and Ekiti have been ranked top in COVID-19 vaccination.

The NPHCDA Executive Director, Dr. Faisal Shuiab, disclosed this on Monday in Abuja at the National Briefing of the Presidential Steering Committee on COVID-19.

“We have been monitoring how states have been intensifying the ramp-up of COVID-19 vaccination. We have ranked them according to performance.

”As of today, the top five states are, 1st: Ogun State, 2nd: Nasarawa State, 3rd: Oyo State, 4th: Osun State and 5th: Ekiti State.

“We will continue to provide you with daily updates of how governors of states are leading the effort to ensure their citizens are fully protected with COVID-19 vaccination,” he said.

On the December 1, 2021, deadline for vaccine mandate for civil servants, Shuaib said that starting from December 1, Federal Government employees would be required to show evidence of being vaccinated against COVID-19, or a negative PCR result done within 72 hours before being allowed into their offices.

“To further ease access to COVID-19 vaccines by government employees, we have also commenced office-to-office vaccination in Federal Ministries, Departments and Agencies.

”What this simply means is that employees who are yet to be vaccinated will find a vaccination site around their offices to register and get vaccinated.

”This will help in preventing the excuse of having to leave their place of employment to a distant vaccination site,” he said.

According to Shuaib, from time to time, civil servants will be picked at random to check or assess their COVID-19 antibody titre to detect persons who may have fraudulently acquired the vaccination cards without vaccination.

 ”Anyone who has been found to have fraudulently obtained the vaccination card without vaccination would be handed over to the law enforcement authorities.

”The vaccines are free and are available at sites close to you.

“We have also engaged and are collaborating with the Nigerian Military, Police and the Para-Military institutions in the establishment of mass vaccination sites in their locations around the country.

”We will also be assisting with the deployment of our vaccination teams to all sites identified by these institutions,” he said.

Shuaib called on Nigerians and residents to take the COVID-19 vaccination.

He said that every COVID-19 infection gave the coronavirus a chance to mutate, adding that being vaccinated helped prevent variants.

”At this point, we would also like to address the myth that says if one has had the COVID-19 disease and has recovered from it, they are protected and do not need to get vaccinated.

P” This is false as studies have shown that if you have had COVID-19 before and are not vaccinated, your risk of getting reinfected is more than two times higher than those who were infected and got vaccinated.

“We are aware that people hesitate to get vaccinated against COVID-19 for many reasons ranging from personal views and fears to logistical problems of getting to vaccination sites.

“But waiting too long to be vaccinated allows the virus to continue spreading in the community with the emergence of new variants.

“Severe COVID-19 can be very dangerous, so the sooner you get vaccinated, the sooner you are protected,” he said.

The NPHCDA boss said this was a period of intensive drive to protect Nigerians against this new variant and indeed a 4th wave of the COVID-19 pandemic.

He said the Agency was not taking anything for granted and not compromising on safety and standards, but fully monitoring all adverse events following immunisation.

”But as I have always appealed, we need the support of all Nigerians. 

”We need every vaccinated Nigerian to appeal to their family members, their loved ones, their neighbours, and members of their communities to get vaccinated so that we are all protected.

”It is indeed a collective responsibility,” he said.

According to him, this is a clarion call to those who had yet to be vaccinated to hurry up and take advantage of our mass vaccination campaign to receive COVID-19 vaccines.

Shuaib said that those who had received their first dose should also endeavour to go and get their second dose on their due dates, for full protection. 

(NAN)

Cultural Intelligence For Leaders

0
80 hearty cheers to an Icon: Sir Ifeanyi Atueyi
Pharm. Sesan Kareem

Today, if you are a business owner, an executive or someone working in a multinational company, there is a high probability that you will have other nationals in your company, or as a business partner or an associate. However, even if you are one of the few people who have always worked with only Nigerians, I strongly believe they will have different backgrounds, ethnicities, religions and ways of life. Therefore, there is need to develop cultural intelligence, in order to have a successful and strong relationship with people from other cultures. This will enhance our job and business performance, as well as help us in our career advancement.

Culture and cultural intelligence

Culture encompasses the values, customs and norms that a group of people share. In other words, it is the way of life of people that determine the standard of their behaviour.

Cultural intelligence is an outsider’s ability to interpret someone’s unfamiliar and ambiguous gestures in the same way the person’s compatriots would.

Culture determines the parameters of the socially acceptable behaviour in a society while individuals in the society determine their behaviour. This is the major reason why individuality shapes behaviour in the society, and not just culture.

Understanding cultural differences

There are remarkable differences in how people from different cultures think, communicate, relate, make decisions, solve problems, build trust and give feedbacks.

For instance, when it comes to power distance, Nigeria, China and Russia are high-power distance countries, while America, United Kingdom, and France are low-power distance countries. Power distance is the extent to which a member of a culture expects and accepts that power is distributed unequally. In other words, the relationship between a boss and a subordinate working together in Lagos is quite different from their counterparts working together in Los Angeles.

Decision shapes destiny.  Different organisations have their process of making decisions. Also, different cultures have different ways of making decisions, independent of power distance. Some cultures value consensus in decision making, others operate top down decision making process.

In America, a boss maintains a low-power distance with his workers; however most decisions are top-down. In Japan, there is a high-power distance relationship but decision making is consensus.

The time it takes to make a decision is also important. A Japanese conglomerate will painstakingly plan its decisions and once made it is final and implementation is pretty fast. An American start-up will make quick decisions but subject to continued adaptation during implementation.

Let’s look at how people from different cultures think. We have specific thinkers and holistic thinkers. A specific thinker analyses a problem or an object by isolating it from his environment.  Europeans and North Americans are specific thinkers. Cultures that think specifically are either principles-first thinkers or applications-first thinkers.  The French and the Russians are principles-first thinkers; whereas, the Canadians and the British are application-first thinkers.

A holistic thinker analyses a problem or an object by considering the environment in connection to the object. Asians and Africans are holistic thinkers. To make this practical, the way you prepare your presentation for a Japanese should be different from the way you prepare your presentation for an American, due to their different ways of thinking.

What about effective ways of building business trust with people from different cultures? In Nigeria, personal relationships are at the core of business relationships. In other words, for you to succeed as a business leader in Nigeria you must developed excellent interpersonal skills.

A typical successful Nigeria business leader knows the importance of attending social functions, being a member of a prestigious club and attending lunch or dinner with a client. For Nigerians to trust you, knowing you is more important than your competence. On the other hand, a German will trust you sorely based on your past performance or quality of work.

Communication is the cornerstone of business. Inability to effectively communicate can harm productivity, performance or profitability. However, different cultures have different ways of communicating. Most Americans and Europeans use low-context communication, where what they mean is conveyed directly in their words. On the flip side, most Africans and Asians use high-context communication, where most of what they mean is conveyed in facial expressions, body language, and gestures, not in words.

The major take home based on the above is the fact that people are different, cultures are different and there is no one-size-fits-all in cultural adaptations. We must learn to adapt.

How do you improve your cultural intelligence?

Become aware of your own relative cultural biases:  It is easy to have biases when it comes to our culture compared to others. However, the first step towards cultural intelligence is to be aware of our thinking when it comes to other people’s cultures.

Respect and value cultural differences: Appreciating other people’s cultures for what they are will open our mind to learn about them.

Adapt to accommodate cultural differences: We must develop the ability to adjust to other people’s cultures.

ACTION STRATEGY: Identify your relative cultural biases. Start to respect and value other people’s cultures.

AFFIRMATION: I adapt to other people’s cultures. I am blessed and highly favoured.

Sesan Kareem serves as Co-founder, HubPharm, www.hubpharmcarescom and Principal Consultant, Sesan Kareem Institute, www.sesankareem.com.ng.

Vincent Njar: Foremost Cancer Cure Specialist and Entrepreneur

0

 

Vincent Njar: Foremost cancer cure specialist and entrepreneur
Vincent Njar

In 1999, Distinguished Professor of Medicinal Chemistry and Pharmacology, Vincent Njar, made a decision that might have seemed purely normal for an avid researcher. He had recently been made professor of Organic Chemistry at the University of Ibadan (1996). However, following several research visits from 1996 to 1998, which saw him collaborating with the late internationally renowned breast and prostate cancer researcher, Dr Angela Brodie, he decided to join her fully at the University of Maryland School of Medicine (UMSOM), in Baltimore, USA. Not only has that decision paved way for him to become one of the most successful medicinal chemists and oncopharmacologists but it has also positioned him to give the world a potential definitive cure for cancer.

Brodie was a British biochemist, who had pioneered development of steroidal aromatase inhibitors in breast cancer research. Njar’s partnership with her in developing the inhibitors bolstered his interest in the rational discovery and development of small molecules as anti-cancer agents. Consequently, over the years, he has made outstanding discoveries in the development of novel small molecules with potential for the treatments of a variety of cancers, especially breast, prostate and pancreatic cancers. He invented novel reactions that led to the synthesis novel inhibitors of all-trans retinoic acid (ATRA) metabolism enzyme (CYP26). These inhibitors are also referred to as retinoic acid metabolism blocking agents (RAMBAs). Some of his compounds are by far the most potent RAMBAs known.

 

Hopes well founded

Indeed, there are very strong reasons for the widespread belief that finding a cure for cancer lies in Njar’s works. As earlier noted, his most significant discoveries include retinoic acid metabolism blocking agents (RAMBAs), or novel retinamides (NRs), that inhibit the growth of breast and prostate cancer cells and tumours. The NRs he discovered cause degradation of mitogen-activated protein (MAP) kinase-interacting kinases (Mnk1 and 2), which can promote tumour progression.

Njar also has worked on the design, discovery, and clinical translation of Galeterone, a novel CYP17 inhibitor/androgen receptor degrading agent for the treatment of cancer. Galeterone was licensed by Tokai Pharmaceuticals, Inc. and advanced to Phase 3 clinical trials showing dramatic activity in men with hormone refractory metastatic prostate cancer. Because of its clinical efficacy, Galeterone and subsequent variants continue to be developed as novel therapeutics for prostate and pancreatic cancers.

Njar said of his on-going research effort: “I am relentlessly pursuing the development of Galeterone technology toward commercial success and medical impact. For example, two clinical trials were initiated just this year, based on recent preclinical studies from my lab. Specifically, we demonstrated that Galeterone impedes pancreatic cancer cell migration, invasion, and proliferation and inhibits tumour growth in mice.”

 

Consummate academic and entrepreneur

Another engagement that Njar finds gratifying is passing on the knowledge and experience he has garnered over the years to other potential world-changers. According to him, “Through collaboration with Dr Brodie, I was able to acquire astute knowledge of cancer biology and oncopharmacology. This enabled me to train 11 PhDs in molecular medicine/life sciences, many postdoctoral fellows, and research associates who have all proceeded to reputable positions in academia, industry, and government.”

Aside from being professor of Medicinal Chemistry and Pharmacology, Njar also heads the Medicinal Chemistry Section of the Centre for Biomolecular Therapeutics (CBT) at UMSOM.  He has published over 120 articles, reviews and book chapters and is the lead inventor on over 50 issued patents and pending patent applications. He actively participates in several drug discovery and development grant review committees nationally and internationally. His research is currently supported by the US National Institutes of Health (NIH) and the National Cancer Institute (NCI)

But perhaps what gives Njar the greatest joy is being an entrepreneurial scientist, who is actively making a difference in people’s lives with his researches and inventions. During a recent presentation, he explained why he chose to combine entrepreneurship with his academic acumen. He said, “In drug development, I could be called academic, but some drug discovery efforts are anything but academic. Academic’s synonym is pedantic. Academic means it doesn’t matter…I want to do things that matter. I certainly don’t want to be associated with the term pedantic…When somebody is called an academic, it should mean that it does matter.”

To back up his words with actions, Njar has taken his research discoveries a step further by founding two companies over the years that have helped him to direct the early development of his inventions and technologies. He first founded Terpene Pharmaceuticals, LLC. Thereafter, in 2018, he co-founded Isoprene Pharmaceuticals, Inc. (IPI), an early-stage small molecule oncology company developing oral therapeutics for triple negative breast cancer and other cancers.  IPI was recently awarded a two-year, approximately $2 million Small Business Innovation Research grant from the National Cancer Institute (NCI) for a translational project to develop a novel therapeutic for triple negative breast cancer.

As the company’s chief executive officer, Njar is focused on oncology applications of the NRs developed in his laboratory.   He reveals what has made him a successful entrepreneur so far: “Being an entrepreneur means to undertake a high-risk, high-reward venture and be fearless in the process. Over the years, I have realised that entrepreneurship means doing, doing, doing until something useful or impactful gets made. I believe in what I am doing, and I am not afraid to ask for help. Being a successful entrepreneur requires thorough planning, creativity, and hard work.”

 

Career path and recognitions

Prof. Njah obtained B. Sc. in Chemistry at University of Ibadan in 1976 and went on to obtain a Ph.D. in Organic Chemistry in 1980 from University College London/University of London (UK). Following two years of postdoctoral research at Worcester Foundation for Experimental Biology, Shrewsbury, Mass. (USA), he joined the Department of Chemistry at the University of Ibadan (Nigeria) as Lecturer II. He was promoted through the ranks and became professor of Organic Chemistry in 1996.

During his tenure at University of Ibadan, he was visiting Professor at several institutions, including: Johns Hopkins University, Baltimore, USA (1988, 1989, 1992 and 1993); Universite de Sherbrooke, Sherbrooke, Quebec, Canada (1990); University of Southampton, Southampton, UK (1991, 1992 and 1995); and University of Saarland, Saarbruecken, Germany (1994-1995). He joined the University of Maryland School of Medicine in 1999.

Njar has been severally honoured for his extraordinary contributions to cancer research, which have  enhanced cancer patients’ care and survival. Early this year, he was made a distinguished professor, which represents the highest appointment bestowed on a faculty member at University of Maryland, Baltimore (UMB), recognising excellence as well as impact and significant contribution to the nominee’s field.

His latest honour was being named,UMBs 2021 David J. Ramsay Entrepreneur of the Year – for his novel discoveries on possible cures for cancer. While introducing him for the award presentation, Albert Reece, executive vice president for medical affairs, UMB, and dean, UMSOM, said of Njah: “Dr Njah is an entrepreneur par excellence. First and foremost, he is an outstanding scientist. He has more than $2½ million of extramural research funding active at the present time. For his profound and creative research, and his collaborative and congenial style of finding solutions, Dr. Njar is what I would describe as the epitome of what a biomedical entrepreneur should be.”

Njar himself described the award as “very encouraging and has energised me to keep plugging on. I am optimistically cautious that my entrepreneurship will eventually produce at least one U.S. Food and Drug Administration-approved anti-cancer drug for the benefit of mankind.”

Dose-related adverse effect caused by phenytoin is:

4

Dose-related adverse effect caused by phenytoin is:

a) Physical and psychological dependence

b) Exacerbated grand mal epilepsy

c) Gingival hyperplasia

d) Extrapyramidal symptoms

Omicron: WHO Warns of ‘High Infection Risk’ Around Globe

0
Omicron: WHO Warns of ‘High Infection Risk’ Around Globe

The World Health Organization (WHO) has warned that the Omicron coronavirus variant poses a high risk of infection surges around the globe.

The variant could lead to severe consequences in some regions, the WHO said on Monday.

The head of the organisation, Dr Tedros Adhanom Ghebreyesus, renewed a call for a global push to get vaccines to poorer nations.

Covid-19 is “not done with us” yet he warned.

The variant was detected in South Africa earlier this month with initial evidence suggesting it has a higher re-infection risk. South Africa has been praised for its prompt reporting of the variant.

“Omicron has an unprecedented number of spike mutations, some of which are concerning for their potential impact on the trajectory of the pandemic,” the WHO said.

Speaking on Monday, Dr Tedros said scientists around the world are working to discover if the new variant is associated with higher transmission, risk of reinfection and how it reacts to vaccines.

“Omicron’s very emergency is another reminder that although many of us think we are done with Covid-19, it is not done with us,” he said.

He added that no deaths have been linked to the new variant yet.

  • How worrying is the new Covid variant?
  • How do you detect Omicron?

Cases have already been reported in a number of countries including Canada, the UK, Portugal, Belgium and the Netherlands.

The new variant has prompted the UK, EU and US to issue a travel ban on Southern African countries – a decision criticised by South Africa’s President Cyril Ramaphosa.

Japan has announced it is closing its borders to new foreign visitors from midnight on Tuesday, while Australia has paused its long-awaited plan to ease border restrictions.

Travel into Australia for international students and “skilled workers” holding visas was meant to re-start on Wednesday but has now been delayed until 15 December.

Israel has also banned foreigners from entering the country.

In the UK, Covid booster jabs are set to be offered to all over-18s to help stop a new wave driven by Omicron.

The US has also followed suit with Joe Biden telling Americans to “go get your booster”. He also urged people to wear masks indoors.

But Mr Biden also said he did not anticipate any further US travel restrictions or lockdowns at this time.

There have been more than 261 million cases and five million deaths around the globe since the pandemic started in 2020, according to data from Johns Hopkins University.

 

Nigeria Has No Case of Omicron COVID, Says NCDC

0

 

The Nigeria Centre for Disease Control (NCDC) has disclosed that no case of new COVID-19 variant, Omicron, has been found in Nigeria as at 28 November, 2021.

NCDC Director General, Dr Ifedayo Adetifa, said the Federal Ministry of Health (FMOH) and his agency are monitoring emerging evidence on the new variant and its implication, to inform Nigeria’s response to the COVID-19 pandemic.

Although he noted that Omicron has not been designated a variant of concern by the World Health Organisation (WHO), but it has been detected in several countries like the UK, Israel, Botswana, Hong-Kong, Germany, Belgium, Italy and counting. While no deaths have been attributed to this new variant yet, a total of 126 genomes of the variant have been detected globally and published on GISAID, (GISAID is a global mechanism for sharing sequencing data).

In a press release sighted by Pharmanewsonline, Adetifa on Monday doused the widespeade tension about the new variant evading protective immunse responses or being vaccine resistant, stating that though the variant is highly transmissible but it has still be detected with existing Polymerase Chain Reaction (PCR) tests. “However, the fears about its ability to evade protective immune responses and/or its being vaccine resistant are only theoretical so far. This virus can still be detected with existing Polymerase Chain Reaction (PCR) tests”.

He continued: “The WHO and researchers across the world are working at speed to gain understanding of the likely impact of this variant on the severity of COVID-19 and on the potency of existing vaccines and therapeutics.

“The Federal Ministry of Health (FMOH) and Nigeria Centre for Disease Control (NCDC) are aware of reports of a new COVID-19 variant – the B.1.1.529 lineage. This SARS-CoV-2 variant has now been designated a variant of concern (VOC) and named; Omicron by the World Health Organisation (WHO) as advised by the independent Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE). WHO has also urged countries to enhance their surveillance and virus sequencing efforts to increase their understanding of the circulating variants.

“The FMOH and NCDC is monitoring emerging evidence on this new variant and its implication, to inform Nigeria’s response to the COVID-19 pandemic.

“The variant was first identified from testing done on 9th November 2021 in Botswana on travellers from West Africa. It was reported to WHO on identification of cases among a cluster of young unvaccinated people in South Africa on 24 November 2021″ he revealed.

The NCDC boss  assured Nigerians on the agency’s efforts in ensuring daily review of surveillance data while using this to inform public health decision making. He urged all states to ensure that sample collection and testing are accessible, so that travellers, people with symptoms or who have been exposed to COVID-19 cases get tested promptly.

He said the NCDC, through the National Reference Laboratory (NRL) continues to coordinate genomic surveillance and other activities required for the detection of variants. The NCDC assumes global spread of this variant has occurred and it is prioritising sequencing of recently accrued samples from SARS-COV-2 positive travellers from all countries, especially those from countries that have reported the Omicron variant already.

In collaboration with Port Health Services of the Federal Ministry of Health, Adetifa noted that enhanced surveillance is ongoing at the airports and points of entry, and to ensure compliance with current travel guidance especially for the day 2 COVID-19 PCR testing. Should there be any changes to travel guidance, this will be communicated in due course.

To prevent widespread of Omicron variant and its emergence that is linked to unmitigated community transmission of the virus, the NCDC urged Nigerians to ensure strict adherence to the proven public health and social measures in place, which are enforceable by the Presidential Steering Committee on COVID-19 (PSC-COVID-19), through the COVID-19 Health Protection Regulations 2021.

“We are collectively responsible for our own health security including playing our part to reduce the risk of the importation or spread of the Omicron variant in Nigeria”, he warned.

 

Select the appropriate consideration for phenytoin:

7

Select the appropriate consideration for phenytoin:

a) It blocks sodium channels

b) It binds to an allosteric regulatory site on the GABA-BZ receptor and prolongs the openings of the Clchannels

c) It effects on Ca2+ currents, reducing the low-threshold (T-type) current

d) It inhibits GABA-transaminase, which catalyzes the breakdown of GABA

Pregnant Women With Small Pelvises, Big Babies Shouldn’t Refuse CS, Gynaecologist Warns

0
Pregnant Women With Small Pelvises, Big Babies Shouldn't Refuse CS, Gynaecologist Warns
Pregnant Women With Small Pelvises, Big Babies Shouldn’t Refuse CS, Gynaecologist Warns

A Professor of Obstetrics and Gynaecology at the Ahmadu Bello University, Zaria, Solomon Avidime, has advised pregnant women with small pelvises to stop refusing caesarean section delivery because of cultural and religious beliefs.

The gynaecologist cautioned that such refusal comes with many risks, warning that delivering a baby through a small birth canal when the baby is big could cause serious complications, including the death of the baby.

Prof. Avidime noted that if a pregnant woman has a small pelvis, the possibility of vaginal delivery is limited, noting that such women are usually offered a CS option to avoid complications.

Speaking in an interview with NAN, the professor, however, said women with small pelvises could still give birth vaginally, depending on the size of their babies.

Giving insight into the risk of forcing babies out of a small birth canal, Prof. Avidime said, “When the pelvis is small and the baby is small, the woman can still have a vaginal delivery. So, the size of the baby is very important here. If a woman has a small pelvis and the baby is big, it will not be wise to allow the baby to pass through that small pelvis.

“Occasionally, we encounter women that will refuse CS, if it is offered to them, as a way to aid their delivery.

“They often refuse such an offer because of their cultural and religious beliefs.

“Some of them have ended up regrettably losing their babies because, by the time they eventually agree, the situation would have become worse. They usually have an outcome that is unwanted.

“Now, if a woman that is to deliver through CS refuses, obviously, she cannot deliver on her own, or even if she eventually delivers, she will have complications and the baby may die. Also, the mother can have injuries, bleeding and may die.”

He pointed out that babies forced out of a small birth canal could also have deformities later in life.

Working Hard is Never Old School

0

 

Brian Tracy- endorsed speaker and training consultant
George O. Emetuche

“Without hard work, nothing grows but weeds.”

– Gordon B. Hinckley

Firstly, I congratulate the Pharmaceutical Society of Nigeria for the successful hosting of the 94th edition of the PSN conference in Port Harcourt, Rivers State. It was a great outing!

This December edition of my article is the last for the year. I thank God for the gift of life. May our careers, businesses and families continue to flourish. Amen.

This article will explore nuggets that will help salespeople and other professionals, no matter the industry or career path. It will prepare you for the New Year.

 

An interesting feedback

I wrote an article on 18 October, 2021, where I explored my daily motivation. In the Nuggets, I listed ten tips that lead to success. Number two on the list says, “The harder and smarter you work, the luckier you get; success and hard work are interwoven.”

I love constructive criticism; it expands knowledge. One reader of the article who belongs to one of our affiliate social media platforms in Enugu didn’t agree with the Nugget assertion. Consequently, he wrote thus, “You don’t need to work hard to be successful; rather, work smart and that’s intelligence. Working HARD means struggling with life. Only few make it that way.”

He was constructive in his position, hence my decision to write this piece – to dig deeper into the topic: Working hard and working smart.

 

What I discovered

Let me tell you that 100 per cent of successful people I know work hard. They got to the top by working hard, with the right vision, mission, goals, and objectives. They applied the right strategies at the right places.

I have studied the lives of more than 100 very successful people and I must tell you that four attributes stand out in their lives:

  1. They are visionary
  2. They are strategic
  3. They work hard
  4. They are consistent

 

Show me a successful man who doesn’t believe in working hard, and I will show you the most popular magician of the century! Without hard work, nothing grows but weeds; I totally agree with this thought.

In my upcoming book Starting and Growing a Successful Business I explored my concept of “The Big Ten.” One of the concepts there is Process.

 

The place of process

Process is like a chef in a five star hotel who knows the right ingredients for the right soup. He also knows the time to use each ingredient. The right process gets the right results.

 

Success in business is about process; it is a journey. There’s no sudden successful entrepreneur! You must go to work if you truly want to succeed.

I woke up at 2:45 am to pen down this article and I finished it at 6:05 am. That’s working hard. I must create it to bring it to life. There’s no other way! That’s process. If I didn’t wake up to write it at that time, I might lose the inspiration to write this piece. Process is hard work. Working hard is following the precepts of process.

 

Tilling for gold

Gold is hidden beneath the soil. If you dig, you discover it. This is working hard and following a defined path to mining gold. Tiling of the ground to discover gold is the “working hard” aspect of success. There should be process before success. No real success stands alone; it must follow a path.

As a professional, or someone trying to start a business, don’t allow anyone deceive you to believe that you don’t need to work hard; that you only need to work smart. Your smart work must stand on a strong foundation of planning, executing and knowing the process that gets things done. What is working smart without believing in working hard? I need a superior explanation please!

 

What I think

You see, I have issues when folks use the line: “I don’t work hard, I work smart.”

What I have found out is that people who say this can’t even dissect the meaning of the sentence. They simply can’t explain the statement. The statement is vague!

I believe that you can’t get to the top when you don’t know how to climb. You must follow a means to get to the top. Working smart without believing in working hard is like telling someone to get to the top without using a ladder, an elevator or any means to the top.

 

Real success is a journey; it has a foundation

Success cannot stand alone. It is a journey that takes off from somewhere. It follows a defined path. Real success takes sweat. It takes thinking, planning, executing and monitoring.

People who promote “I don’t work hard, I work smart” see working hard as not being smart. Are you kidding me? How on earth would someone discount working hard on his path to success? Success and working hard are cousins!  (Continues next edition)

 

George O. Emetuche, CES, MNIMN, is a Brian Tracy endorsed bestselling author, accredited training consultant, life coach, sales and marketing expert.

Please buy books by George O. Emetuche. They are:

  1. The Selling Champion
  2. The Art of Selling
  3. The 25 Unbreakable Laws of Sales
  4. The 11 Irrefutable Principles of Success
  5. Everything is Possible
  6. Be Inspired!
  7. Succeeding With Your Spouse

Get them from popular bookshops, pharmacies or super stores near you. Reach us on 07060559429 or 08186083133, for cutting edge training of your Sales Team and other Professionals. Let’s take care of your Sales Conference. We know The Art of Selling!

 

www.thesellingchampionconsulting.com.

PCRs Detect Omicron COVID-19 Variant, Studies Underway For Other Tests, Says WHO

0
PCRs Detect Omicron COVID-19 Variant, Studies Underway For Other Tests, Says WHO
PCRs Detect Omicron COVID-19 Variant, Studies Underway For Other Tests, Says WHO

While PCR tests can detect infection with Omicron, studies are looking to whether the COVID-19 variant of concern has any impact on other test types, the WHO said Sunday.

“The widely-used PCR tests continue to detect infection, including infection with Omicron, as we have seen with other variants,” the World Health Organisation said in an update on what is known so far about the new variant.

“Studies are ongoing to determine whether there is any impact on other types of tests, including rapid antigen detection tests.”

The WHO on Friday declared Omicron, first detected earlier this month in southern Africa, to be a variant of concern.

The classification put Omicron into the most troubling category of COVID-19 variants, along with the globally dominant Delta, and its weaker rivals Alpha, Beta and Gamma.

Omicron spread across the globe on Sunday, shutting borders and renewing curbs as the EU chief said governments faced a “race against time” to understand the strain.

The variant has cast doubt on global efforts to battle the pandemic due to fears that it is highly infectious, forcing countries to reimpose measures many had hoped were a thing of the past.

In its update, the WHO said it was “not yet clear” whether Omicron spreads more easily from person to person, or whether infection with the variant causes more severe disease compared to other strains.

“There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants,” the UN health agency said.

While preliminary evidence suggests there may be an increased risk of people who previously had Covid being reinfected with Omicron, information is currently limited.

The WHO said it was working to understand the potential impact of the variant on existing countermeasures, including vaccines.

As for treatments, the organisation said corticosteroids and IL6 receptor blockers would still be effective for managing patients with severe Covid-19 — while other treatments would be assessed to see if they are still as effective against Omicron.

The WHO has said studies into various aspects of the new variant would take several weeks to reach conclusions.

“WHO is coordinating with a large number of researchers around the world to better understand Omicron,” it said.

“More information will emerge in the coming days and weeks.”

(AFP)

Stop Excessive Use of Antibiotics, NAFDAC Warns Nigerians

0
Blue and White Antibiotics

The National Agency for Food and Drug Administration and Control has warned Nigerians against taking excess antibiotics, saying it accelerates the process of Antimicrobial Resistance and leads to avoidable deaths.

The warning was contained in a statement signed by the agency’s resident media consultant, Mr. Olusayo Akintola, and issued to newsmen on Sunday.

The statement stated that the Director-General of the agency, Prof. Moji Adeyeye, disclosed this during a virtual meeting/2021anniversary of World Antimicrobial Resistance Week.

The theme for this anniversary is “spread awareness, stop resistance,” where Adeyeye sounded a warning that

if allowed to fester, antimicrobial resistance could lead to death.

She added the war against AMR has not only gained prominence and global attention but also has become a significant battle that the human race must win.

‘’It is in view of this fact; I am delighted to be part of this battle and welcome all our esteemed stakeholders to the front line of this battle. Creating awareness amidst us all is a major step in AMR stewardship to effectively stop resistance.

“The step is unique and is expected, not only to redirect our way of handling and use of antimicrobial agents but also to yield a significant reduction in the incidence of AMR.

“NAFDAC is using the stakeholders’ meeting to mark her participation in the year 2021 World Antimicrobial Awareness Week, targeting professionals in the Healthcare sector, including veterinarians, Animal Husbandry professionals in livestock production, Plant Pathologists, and individuals that use antimicrobial agents,” she said.

Adeyeye expressed dismay over the development and proliferation of AMR, saying that the ability of the pathogenic microorganism to resist the effect of antimicrobial agents when used has compromised the ability of antimicrobials to effectively treat infectious diseases as expected.

According to her, the emergence and spread of drug-resistant pathogens continue to weaken the health systems,’’ she stressed.

Adeyeye said that the fight against AMR requires collective efforts that are interlinked and interphased along with the One-Health Concept, adding that NAFDAC had put in place some important regulatory measures to curb the emergence and spread of AMR.

According to her, “this is necessary and extremely important to ensure food safety, food security, a safe environment, and a healthy citizen in our dear country.”

She added that everyone in the healthcare, livestock production and environmental management sub-sectors of the economy is directly or indirectly involved in curbing AMR.

Adeyeye reaffirmed NAFDAC’s commitment to ensuring that only safe and wholesome food, drugs, and other regulated products are available to Nigerians.

She said ‘’the agency is now more dedicated to the delivery of quality services to our stakeholders thus the agency’s slogan which brought about the slogan “customer focus…, agency minded” which has been entrenched in our operations of the agency.

She said that the agency seeks to strengthen collaboration with stakeholders, sister Ministries, Departments & Agencies (MDAs) both at state and federal levels, towards a more effective regulation and active involvement in creating awareness about AMR.

She insisted that ignorant among professionals would be a serious setback in bringing to an end the emergence and spread of AMR.

She said that the agency’s stake in the protection of public health, as entrenched in NAFDAC Act Cap N1 LFN 2004, is to ensure that regulated products that are available for use are wholesome, safe and of the right quality.

She stated that the agency, in fulfilling this mandate towards combating AMR, is adding impetus to her regulatory activities through industrial outreach and collaboration with stakeholders as wee as fostering synergy within her technical directorates.

She said that the aim is to attain a seamless regulatory process and ensure that the distribution and use of regulated products are effectively controlled through robust Post-Marketing Surveillance.

Adeyeye disclosed that the agency had amidst other regulatory actions, reviewed the formulation of all antibiotics to prevent the excessive use of multiple Active Pharmaceutical Ingredients and banned the use of antibiotics as a growth promoter in livestock and fish production.

The NAFDAC boss further explained that the agency had banned the use of antibiotics and gentian violet as a mold inhibitor in animal feed.

She said that the agency had also introduced the Mobile Authentication Service, a mechanism for detecting counterfeit antibiotics by consumers.

She added that NAFDAC had also organised roadshows and public enlightenment on the appropriate use of antimicrobial agents to promote the safe and judicious use of antibiotics.

According to the director-general, several factors have perpetuated the accelerated AMR occurrence; which contributed in various ways to the problem.

She noted that misuse resulting from overuse and underuse of antimicrobial agents has been identified as the main causes and implicated in the increasing trend of resistant pathogens in both human and animal populations.

“Consequently, minimising the emergence and spread of AMR requires a coordinated, focused multi-sectoral and multinational effort,’’ she stressed. 

(NAN)

Omicron: South Africa President Wants ‘Urgent’ Lifting of Travel Bans

0
Omicron: South Africa President Wants ‘Urgent’ Lifting of Travel Bans

President of South Africa, Cyril Ramaphosa on Sunday called on countries to “immediately and urgently” reverse scientifically “unjustified” travel bans linked to the discovery of the new coronavirus variant Omicron.

Dozens of nations from Europe to Asia have blacklisted South Africa and its neighbours since South African scientists flagged Omicron on November 25.

The flight bans have angered several African leaders.

“We call upon all those countries that have imposed travel bans on our country and our southern African sister countries to immediately and urgently reverse their decisions,” Ramaphosa said in his first address to the nation following last week’s detection of the new variant.

The World Health Organization has labelled Omicron a variant of concern, while scientists are still assessing its virulence.

A “deeply disappointed” Ramaphosa argued that the ban was “not informed by science”.

The countries that have already imposed travel restrictions on southern Africa include key travel hub Qatar, the United States, Britain, Saudi Arabia, Kuwait and the Netherlands.

– ‘Afrophobia’ –

Earlier Sunday, Malawian President Lazarus Chakwera accused Western countries of “Afrophobia” for shutting their borders.

And in Botswana, the other southern African country to detect the strain — among a group of foreign diplomatic visitors in the first instance — two ministers cautioned against “geo-politicising this virus”.

“We are concerned that there seem to have been attempts to stigmatise the country where it was detected,” Health Minister Edwin Dikoloti, said on Sunday. 

The head of the WHO in Africa was equally worried.

“With the Omicron variant now detected in several regions of the world, putting in place travel bans that target Africa attacks global solidarity,” said WHO regional director general Matshidiso Moeti in a statement.

Ramaphosa warned that the travel ban would “further damage the economies (and) undermine their ability to respond to and recover from the pandemic”.

South Africa, the continent’s most industrialised country, is struggling with slow economic growth and a more than 34 percent unemployment rate.

The travel curbs are another major blow to its key tourism industry, which had set high hopes on the upcoming southern hemisphere summer. 

– ‘Unjustified restrictions’ –

Ramaphosa blasted the G20 countries for abandoning commitments made at a meeting in Rome last month to support the recovery of the tourism sector in developing countries.

On Sunday, he added: “Instead of prohibiting travel, the rich countries of the world need to support the efforts of developing economies to access and manufacture enough vaccine doses for their people without delay.

“These restrictions are unjustified.” 

Ramaphosa called on rich countries to stop fuelling vaccine inequality, describing jabs as the “most powerful tool” to limit Omicron’s transmission.

He once again appealed to South Africans to get their vaccines and said the government was considering making vaccines mandatory for certain activities and locations in a bid to increase uptake.

“Vaccines do work,” he said. “Vaccines are saving lives.”

Just over 35 percent of adults in South Africa have been fully inoculated after a slow start to the vaccine campaign, with vaccine hesitancy widespread. 

The country is Africa’s worst hit by COVID-19, with around 2.9 million cases and 89,797 deaths reported to date.

Omicron is believed to be fuelling a rise in infections, with 1,600 new cases recorded on average in the past seven days compared to 500 the previous week.

(AFP)

Millet, Healthy Ancient Grains

0

 

Millet, healthy ancient grains
Millet

Millet is a cereal grain that belongs to the Poaceae family, commonly known as the grass family. Botanically known as Panicum miliaceum, millet is called dawa in hausa, achara in igbo and okababa in Yoruba. Millet is a small, round whole grain grown in India, Nigeria, and other Asian and African countries. It comes in varieties that differ in colour, appearance, and species. Pearl millet is the most widely produced variety intended for human consumption. Still, all types are renowned for their high nutritional value and health benefits.

Constituents

Millet is rich in calories, fat, carbohydrate, dietary fibre, protein, vitamins (like folate, niacin, pantothenic acid riboflavin, thiamine, pyridoxine, vitamin E, tocopherol alpha, vitamin K), calcium, iron, copper, magnesium, manganese, phosphorus, potassium, selenium and zinc. Millet is also rich in phenolic compounds, especially ferulic acid and catechins.

 

Preparations

It is common to see millet sold dried, puffed like rice, or ground like wheat flour. It may be soaked, fermented, boiled, toasted or baked. This grain is processed to make snacks, pasta, and nondairy probiotic beverages, breakfast porridge, side dish, salad add-in, or cookie or cake ingredient. Dried millet can be cooked like couscous or quinoa.

 

Pharmacological actions and medicinal uses

The ferulic acid and catechins act as antioxidants to protect the body from harmful oxidative stress. Studies in mice link ferulic acid to rapid wound healing, skin protection, and anti-inflammatory properties. Catechins bind to heavy metals in your bloodstream to prevent metal poisoning.

Millet is rich in fibre and non-starchy polysaccharides, two types of undigestible carbs that help control blood sugar levels. This cereal also has a low glycemic index (GI), meaning that it’s unlikely to spike the blood sugar levels. For instance, a study in 105 people with type 2 diabetes determined that replacing a rice-based breakfast with a millet-based one lowered blood sugar levels after the meal. A 12-week study in 64 people with prediabetes gave similar results.

Millet helps in slowing down muscle degradation, aids in sleep, helps in relieving menstrual cramps, aids breast milk production and improves skin elasticity. Millet contains tryptophan, an amino acid that lowers appetite and helps in managing weight. It digests at a slower rate and keeps the stomach full for a longer period of time. Millets are high in fibre and satiate hunger quickly, preventing from overeating. People who want to lose weight should incorporate millets in at least one of their main meals.

Foxtail Millet contains both fibres and phytonutrients, the combination of which is believed to reduce the risk of developing colon and breast cancers.

Magnesium present in millet causes relaxation of the muscles that line the inside of the arterial wall, which helps to reduce blood pressure. Millet also reduces the severity of asthma, frequency of migraines and relieves menstrual cramps. Tryptophan in millet raises the serotonin level in the body which helps in reducing stress.

 

Adverse effects

Millet contains antinutrients — compounds that block or reduce your body’s absorption of other nutrients and may lead to deficiencies. For example, one antinutrient called goitrogenic polyphenols interferes with the production of thyroid hormones and inhibits iodine uptake and utilisation by the thyroid gland, causing goitre.

 

Economic uses and potentials

 

Millets are traditionally important grains used in preparing alcoholic beverages and brewing millet beer in some cultures.  A 120kg bag of millet cost N10,500 in 2018,  N15,500 in 2020 and N26,000 in 2021. The global millets market is set to cross USD 12 billion by 2025. Opportunities abound in the cultivation, distribution, sales, pharmaceutical, food and beverages industries.

 

By Pharm. Ngozika Okoye

Pharm., MSc (Clinical Pharmacy), MPH, FPCPharm (Nigeria Natural Medicine Development Agency)

References

Firdous H (2020). Millet health benefits, nutrition value and side effects. Lybrate

Uduak Olayemi Emerges Winner, BOF 2021 Research Grant

0

 

Uduak Olayemi Emerges Winner, BOF 2021 Research Grant
Outgoing Chairman, BOF, Prof. (Mrs) Mbang Femi-Oyewo (right) presenting the cheque of N1 million to the winner, Pharm. (Mrs) Uduak I. Olayemi.

A lecturer in the Department of Pharmacognosy, Faculty of Pharmacy, Obafemi Awolowo University (OAU), Pharm. (Mrs) Uduak I. Olayemi, has been declared winner of the Board of Fellows (BOF) of the Pharmaceutical Society of Nigeria (PSN) 2021 Research Grant, which comes with a cash prize of N1 million.

Presenting the cheque to Olayemi at the BOF’s office in Lagos recently, the outgoing Chairman, BOF, Prof. (Mrs) Mbang Femi-Oyewo, congratulated her for emerging winner out of 32 applicants, following a thorough screening process by the research committee. She noted that the grant is to support  her ongoing research work, which will facilitate easy completion of the project.

The awardee is a PhD student with the research topic, “Isolation and Characterisation of Monoamine Oxidase Inhibitors from South Western Nigerian Plants Relevant in Parkinson’s Disease and Associated Depression”.

According to Femi-Oyewo, “The Board through its committee has worked on modalities to call for submission of research proposals and the guidelines established. Research proposals were received and assessed using external assessors by the committee. The committee has since submitted its report. The winner of the N1m BOF 2021 Research Grant is Pharm. (Mrs) U. I. Olayemi, from Obafemi Awolowo University, Department of Pharmacognosy and Faculty of Pharmacy”.

The erstwhile BOF chairman disclosed that the grant was formerly N300,000, but having considered the effect of inflation in the country and the cost of completing academic research, the committee reviewed it upward to N1 million. She further explained that the award should have been presented at the Annual General Meeting (AGM) of the just concluded 94th Annual National Conference of the PSN, held in Port Harcourt, Rivers State, but due to some personal engagements of the awardee, the Board had to shift it to a future date to allow the winner to be in attendance.

The veteran academician charged  Olayemi to fly the flag of the Board as high as possible, noting that being the winner of the grant had automatically made her a flagbearer of the Board. She also assured the grantee of Board members’ availability to assist in whatever capacity in the course of her project, as the Board expects the publication of her findings in two high impact journals.

“We expect to see the result of the research in two high profile journals. Make the chairman of the Research Grant Committee and myself your mentors, because our objective is to mentor young pharmacists. We are available to guide you through”, she stated.

Femi-Oyewo also mentioned another category of award – the Best Graduating Student Award – which the Board gives to support  best graduating students in their courses of study in all accredited faculties of pharmacy in Nigeria universities.

While revealing  that the award comes with the sum of N50,000 and a plaque, she stated that 23 students from the accredited universities received the prize while she was in office.

Also congratulating the awardee, the Chairman, BOF Research Grant Committee, Prof. Kemi Odukoya, urged her to sustain her culture of diligence, saying that her thoroughness in adhering to the proposal guidelines earned her the award.

“This fund is a challenge for you, as all eyes are on you, your department, faculty and institution for the result,” Odukoya said.

The professor of Pharmacognosy also counselled the grantee to strive to strike a balance between her academic work and family, as one must not suffer for the other.

While charging her to plan the research work in phases, Odukoya told Olayemi that the Board expects progress report of each phase of the investigation on or before due date, as stipulated in her letter.

The awardee was also mandated to renew her practicing licence with the Pharmacists Council of Nigeria (PCN) as soon as possible, saying the Board required a copy of it.

In her response, Olayemi, expressed her heartfelt gratitude to the BOF and the research committee members, assuring them that she would not let them down.

While acknowledging that doing research in public universities is very challenging, she said the grant would help her a great deal in completing the investigation in good time.

Disregard Myths on COVID-19 Vaccine, Health Agency Urges Nigerians

0
Mr Francis Okonkwo, Health Education Officer of the board made the call while delivering a lecture at a one-day media orientation workshop on COVID-19 mass vaccination campaign.
He noted that all the myths on the COVID-19 vaccine were falsehood aimed at discouraging people from taking the jab.
The orientation organised by the healthcare board in collaboration with Breakthrough Action Nigeria was to seek the media partnership in driving the campaign for Nigerians to get vaccinated.
Okonkwo, who spoke on the role of the media in the implementation of the COVID-19 mass vaccination campaign  inaugurated on Nov. 18, in the FCT, encouraged Nigerians to get vaccinated, saying the vaccine does not change the DNA of individual as being speculated.
“The news making round that the messenger RNA technology used in making COVID-19 vaccine is new is not true, and that the vaccine was developed and contains controversial substance are all falsehood.
“The news that the COVID-19 vaccine magnetises substances at the point where it was taking on the body is just a myth,” he said.
He, however, admitted that the vaccine could react differently in the body of individuals owing to body response or the gene substance, which he said was not the same for every individual.
He, therefore, urged Nigerians who  were yet to be vaccinated to disregard  the myth surrounding the vaccine and  go ahead to take the jabs.
He also called on the media to help propagate the campaign about the vaccine, adding that the media were the gate keepers who had the power to change the narratives about all the myths.
According to him, COVID-19 vaccine does not hurt, they are  safe and efficacious.
He called for action to manage the infodemic, adding that infodemic was the issue surrounding COVID-19 vaccine, which some were correct while some were not.
Hajia Nana Yusuf, Head of Advocacy, Communication and Mobilisation, FPHCB, said that the board was targeting 1.5 million Nigerians for vaccination in the FCT before Dec. 31.
She called on the media to assist the board by embarking on aggressive campaign that would reach the nooks and crannies of FCT and spur all adults from 18 years to get vaccinated.
Mrs Salome Tor, Deputy Director Nursing Services, FPHCB, enumerated some of the challenges hindering health workers in carrying  out effectively COVID-19 vaccination.
Tor, who was represented by Mrs Adéyemí Margaret, FCT State Immunisation Officer (SIO) identified various shades of hesitancy across all segment of people including civil servant and health workers as the number one problem.
According to her, thousand of Nigerians have negative thinking about this vaccine, and that there is need to change the narrative.
Some of the challenges, she said, are poor programme funding, recruitment of ad hoc workers for the vaccination with urgent training, as well as poor internet services in checking for data.
Others are poor road network to some communities in FCT, difficulties in accessing first dose vaccination data and insecurity in some part of the community.
Mr Eze Eze, Head, Media Unit, Breakthrough Action Nigeria (BAN), pleaded with the media to use all the channels of communication network by making all Nigerians get vaccinated.
According to him, the media is now the hope of stakeholders that is being relied upon to help drive the campaign about the vaccine and make Nigerians to get vaccinated. (NAN)

WHO Says Only 1 in 4 African Health Workers Fully Vaccinated Against COVID-19

0

The World Health Organisation (WHO) says its preliminary analysis has revealed that only 27 per cent of health workers in Africa have been fully vaccinated against COVID-19.

Dr Matshidiso Moeti, WHO Regional Director for Africa, disclosed this during at a virtual news conference on Thursday.

Moeti said that the analysis was leaving the bulk of the workforce on the frontlines against the pandemic unprotected.

She noted that the analysis of data reported from 25 countries finds that since March 2021, 1.3 million health workers were fully vaccinated, with just six countries reaching more than 90 per cent.

Nine countries have fully vaccinated less than 40 per cent of its health workers.

According to Moeti, in sharp contrast, a recent WHO global study of 22 mostly high-income countries reported that above 80 per cent of their health and care workers are fully vaccinated.

Moeti said that majority of Africa’s health workers were still missing out on vaccines and remained dangerously exposed to severe COVID-19 infection.

She said that unless the doctors, nurses and other frontline workers got full protection, we risked a blowback in the efforts to curb the disease.

“We must ensure our health facilities are safe working environments.

“It is important to have high vaccine coverage among health workers not only for their own protection but also for their patients and to ensure health care systems keep operating during a time of extreme need.

Africa’s shortage of health workers is acute and profound, with only one country in the region having the required health workers (10.9 per 1000 population) to deliver essential health services.

“Sixteen countries in the region have less than one health worker per 1000 population.

“Any loss of these essential workers to COVID-19 due to illness or death, therefore, heavily impacts on service provision capacity.

“Based on data reported to WHO by countries in the African Region, since March 2020 there have been more than 150 400 COVID-19 infections in health workers, accounting for 2.5 per cent of all confirmed cases and 2.6 per cent of the total health workforce in the region.

“Five countries account for about 70 per cent of all the COVID-19 infections reported in health workers, Algeria, Ghana, Kenya, South Africa and Zimbabwe.

“After almost four months of a sustained decline, COVID-19 cases in the general population in Africa have plateaued.

“For the first time since the third wave peak in August, cases in Southern Africa have increased, jumping 48 per cent in the week ending on Nov. 21, compared with the previous week,“ she said.

According to her, the risk of health worker infection rises whenever cases surge.

She said it was a pattern that has been observed during the previous three waves of the pandemic.

According to her, with a fourth wave likely to hit after the end-of-year travel season, health workers will again face risks amid low vaccination coverage.

“To date, more than 227 million vaccine doses have been administered in Africa.

“In 39 countries that provided data, 3.9 million doses have been given to health workers.

“With a new surge in cases looming over Africa following the end-of-year festive season, countries must urgently speed up the rollout of vaccines to health care workers,” Moeti said.

She said that vaccine shipments have been on the rise over the past three months.

She said that Africa has received 330 million doses from the COVAX Facility, the African Vaccine Acquisition Task Team and from bilateral agreements since February 2021.

According to her, of these 83 per cent have been delivered since August alone.

She said as vaccine supply peaked, addressing uptake bottlenecks and accelerating rollout became more critical.

Moeti said that all countries in Africa have prioritised health workers in their vaccination plans. The low coverage is likely due to the non-availability of vaccination services, especially in rural areas, as well as vaccine hesitancy.

“Recent studies found that only around 40 per cent of health workers intended to receive a COVID-19 vaccine in Ghana and less than 50 per in Ethiopia.

“Concerns over vaccine safety and the adverse side effects of the vaccines have been identified as the main reasons for their hesitancy,” she said.

According to her, health workers are key sources of information for the general population and their attitudes can influence vaccine uptake.

“The COVID-19 vaccine stands among humanity’s extraordinary scientific feats. In Africa, we’re gradually overcoming supply constraints. Now is not the time to stumble over vaccine mistrust,” Moeti said.

According to her, to drive up health worker vaccination, WHO is coordinating training and dialogue on vaccine safety and efficacy to help address doubts or misconceptions around the COVID-19 vaccine.

She said the organisation was also advocating open and honest communication about the benefits and side effects of vaccination. (NAN)

Narcoterrorism in the Nigerian Street Context

0
Patrick Iwelunmor

The activities of illicit drug peddlers on Nigerian streets should be a matter of serious concern to our government, not only at the local level but also at the federal level. One must commend the tireless efforts of the National Drug Law Enforcement Agency (NDLEA) which has taken the fight against illicit drug peddlers to almost every nook and cranny of the country.

According to Wikipedia, “Narcoterrorism, in its original context, is understood to refer to the attempts of narcotics traffickers to influence the policies of a government or a society through violence and intimidation, and to hinder the enforcement of anti-drug laws by the systematic threat or use of such violence.”

In the city of Lagos, Nigeria, there are many streets that have become notorious for drug peddling and violence. These streets are populated by young men and women who consume hard drugs, especially marijuana, Colorado, ice and SK. The truth is that these young people are emboldened by the fact that the communities in which they live fear them because of their propensity to unleash mayhem at the slightest provocation.

Many of them argue that they are frustrated hustlers who no longer have any hope in the government. They believe that government has failed them and that the only way they can make a living is to peddle illicit drugs among their peers. Whenever there is a threat to their business from government quarters, they usually respond with other acts of violence to serve as a warning to the authorities to desist from harassing them.

On some of these Lagos streets, there are covert smoking cells where people gather to smoke marijuana in groups. These groups are usually united and can fight a common cause together. Some of the cases of rape, as well as phone and bag snatching that take place on the streets, are actually responses from these groups. They are always trying to make a statement with their actions.

One of the reasons the concept of narcoterrorism has become complicated is that we often look at it from a higher perspective, thinking that only the big and international drug cartels pose the major threats. Unfortunately, with rising unemployment, many youths have ventured into the business of drug peddling in miniature scales. The fact that they are itinerant in their modus operandi should bother any right thinking government. Many undergraduates on Nigerian campuses peddle marijuana and other illicit substances and are known to be the best friends to members of different campus confraternities. There is no cult killing in Nigeria that is not connected to the consumption of one hard drug or the other.

It is therefore pertinent to note that, in deconstructing the behavioural psychology of young drug users, one must put into consideration their social and, if possible, educational status. Most Nigerian undergraduates easily find themselves in the vicious mix of drug-related activities, largely because some of them have not fully jettisoned the excesses that come with adolescence. They are usually hyper-curious and always willing to explore new realities, not minding the consequences. Peer pressure also plays a very significant role in shaping the behaviour of these young drug users who eventually grow into adults and constitute a serious menace to the society.

As stated earlier, most of the cases of street theft, rape and snatching of phones, purses and handbags have their origins in the minds of young people who are high on hard drugs, such as marijuana and other street-side narcotics. And while the war against drug abuse at this level concerns all levels of government, the greater onus lies on the local government which deals directly with the grassroots. In Lagos, the LCDA (Local Council Development Authority) system has proven to be very effective in curbing and controlling the excesses of drug peddlers and their customers.

Being that the LCDA is usually made up of landlords and their tenants, so many criminal activities have been brought to an end through the efforts and strategies put in place by some LCDAs. In many of these communities, landlords have risen to the occasion in the fight against drug peddling because they have discovered that their own children are at risk of being influenced. In fact, some of them have been shocked to find out that their wards are already drug addicts and so, they have joined the fight against the menace of street drug peddling.

Israel Detects New COVID-19 Strain Recorded in South Africa

0
Israel Detects New COVID-19 Strain Recorded in South Africa

Israel has identified a case of a COVID-19 variant with a large number of mutations first detected in South Africa, the health ministry said on Friday.

“The variant discovered in southern African states has been identified in Israel,” the ministry said, adding it was recorded “in a person who returned from Malawi”.

Two more cases were detected in “people returning from abroad”, it said, adding that they had been placed in quarantine.

The three people were all vaccinated, the health ministry said, without specifying the number of doses or the type of vaccine.

News of its spread to Israel comes a day after scientists in South Africa said they had detected the new B.1.1.529 strain with at least 10 mutations, compared with two for Delta.

The variant was of “serious concern” and had been blamed for a surge in infection numbers, authorities in South Africa said Thursday.

It had also been detected in Botswana and Hong Kong among travellers from South Africa, they said.

Israel was one of the first countries to launch vaccines against the coronavirus last year thanks to a deal with Pfizer that gave it access to millions of doses in exchange for data on the vaccine’s efficacy.

More than 5.7 million of the country’s nine million people are now fully vaccinated.

Israeli Prime Minister Naftali Bennett called a meeting on Friday morning with public health officials and his government to take stock of the Covid situation in the country.

The World Health Organisation is due to hold a meeting later Friday to decide if the new strain should be designated a variant of “interest” or of “concern”.

Israel had already late Thursday placed on its “red list” the southern African nations of Botswana, Eswatini, Lesotho, Mozambique, Namibia, South Africa and Zimbabwe because of the discovery of the variant.

Over the summer, the Jewish state experienced an upsurge in coronavirus infections, fuelled by the Delta variant, and launched one of the earliest campaigns for booster shots.

On Tuesday, Israel rolled out COVID-19 vaccinations for children aged five to 11, one of only a handful of countries to inoculate minors that young as it seeks to stem another pandemic wave.

Earlier this month, Israel held a “war game drill” in case of an outbreak of a new lethal variant of COVID-19.

The simulation covered different aspects of a crisis, including mass inoculation, ordering curfews and imposing a flight ban.

(AFP)

FG to Establish Special Courts For Sexual, Gender-Based Violence

0
FG to Establish Special Courts For Sexual, Gender-Based Violence
FG to Establish Special Courts For Sexual, Gender-Based Violence

The Federal Government is to establish special courts to prosecute cases of Sexual and Gender-Based Violence and ensure quick dispensation of justice for victims and survivors.

Minister of Women Affairs, Mrs. Pauline Tallen, disclosed this in Abuja on Thursday at a media briefing commemorating the 16 days of activism against gender-based violence.

The event has as its theme: “Orange the world: End violence against women now!”

Tallen said that with intense advocacy many survivors of rape and GBV had made the violation of their rights public and were seeking legal and judicial assistance.

She, however, said that the lack of survivor-sensitive approaches in court was a major challenge.

According to the minister, the limited number of courts compared to the large volume of cases, geographical distance to the nearest court, language used in courts and rising cases of secondary victimisation, had contributed to the lack of confidence in the criminal justice system by women who are subjected to violence.

From available statistics from the National Situation Room and Dashboard as of Wednesday, Nov. 24, 2021, the total number of cases reported is 5,204.

“Of the figure, 3,125 survivors are demanding justice and only 33 perpetrators have so far been convicted, representing 0.51 percent.

“The fatal cases are 160, closed cases 231, while cases pending in court are 972,” she added.

According to the minister, the ministry has initiated the process of establishing special courts for vulnerable groups.

She added that the ministry would continue to push until it achieved the desired goal of providing legislative backing to punish perpetrators and get justice for victims and survivors.

Also, Ms. Comfort Lamptey, UN Women Country Representative to Nigeria and ECOWAS stressed the need to strengthen a collective response system that would effectively and promptly provide support to victims and survivors of sexual and gender-based violence.

Lamptey explained that GBV was pervasive and as such preventive efforts were pivotal through addressing harmful practices and norms that belittled the rights of women and girls.

She urged men to join in the fight to end the practice.

EU Country Representative to Nigeria, Ms. Samuela Isopi, while decrying the high rate of GBV cases, described it as a “shadow pandemic“ and called for political will and advocacy to stop the trend.

“This year’s activism in Nigeria is geared towards coordinated efforts for a special court in fighting GBV cases.”

Assistant Inspector General of Police, Aisha Abubakar, reiterated the commitment of the force to be more gender-responsive and ensure that all GBV cases were investigated and perpetrators prosecuted.

Dr. Natalia Kanem, UN-SUG and Executive Director, UNFPA, said available data indicate that the prevalence of GBV was high and stressed the need for the rehabilitation of survivors. 

(NAN) 

The Question of Purpose 

1
Your Destiny Course
Pharm. (Sir) Ifeanyi Atueyi

Any person who wants to live a successful life must settle the question of purpose of life. The first and most important question is, what is God’s purpose for my life? What is it that God created me for?  What does God want me to do for Him with my life? What is His assignment for me?

These are fundamental questions that must be clearly answered by every person created by God. And the answers to them must be right for anyone who aspires to live a successful life.

These questions come naturally to everyone and how they are answered determines the direction and destiny of each individual. God is never vague about His purpose for anyone’s life. Instead, He has always been eager to show people why they were created.

God has a purpose for everyone. To be happy and fulfilled, the onus is on each of us to seek out that purpose in order to actualise it. God is extremely interested in your discovery of His purpose for your life. He will gladly let you know this purpose, if you will ask Him. He says in Jeremiah 33:3 (NKJV), “Call to Me, and I will answer you, and show you great and mighty things, which you do not know.”

God is ready to instruct and direct you if you are obedient.  Isaiah 30:21 (NKJV) says, “Your ears shall hear a word behind you, saying, ‘This is the way, walk in it,” whenever you turn to the right hand or whenever you turn to the left.” Also, in Acts 9:6 (NKJV), Paul of Tarsus asked Jesus, ‘’Lord, what do you want me to do?”

God will reward or pay only for the services He has ordered. That means that however hard one works, as long as it is outside the will and plan of God, the service doesn’t count.  In Deuteronomy 28:12, God promised to bless the works of our hands. This implies the works which He has commissioned.

The efforts and resources invested in our services shall be tested. 1 Corinthians 3:15 says, “Each one’s work will become clear, for the Day will declare it, because it will be revealed by fire; and the fire will test each one’s work, of what sort it is. If anyone’s work which he has built on it endures, he will receive a reward. If anyone’s work is burned, he will suffer loss; but he himself will be saved, yet so as through fire.”

As a believer, you are saved but a lot of your services may be wasted because they are not rewarded. No sensible individual would like to do useless work but that is what those working outside God’s will are unknowingly doing.

You go about life with untapped potentials when you are not sure of God’s purpose for your life. You move from one type of business to the other but there is no success or fulfilment. You move from one location to the other, thinking that location is your problem. You establish contacts with influential people thinking that your problem is not connecting with the right people. You work from early morning to late in the night but that does not solve your problem. Psalm 127:1a (NKJV) says, “Unless the Lord builds the house, they labour in vain who build it.”

Living without purpose will make you jealous of other people. You envy others who are flourishing in their God-given assignments and want to be like them.  The person who is in alignment with God’s purpose does not look around to compare himself with others. He is busy with his own assignment and remains focused and committed.  He is fulfilled and contented.

The big question is, have you discovered what you were born to do? Until you do that, you may constitute a nuisance to the society, a square peg in a round hole. You may make a lot of movement but no progress. You are not preparing to give account of your stewardship and yourself when this life is over. You will not be among those to whom Jesus will say, “Well done, thou good and faithful servant.” (Matthew 25:21).

It is important to treat discovery of purpose with a sense of seriousness and urgency because life is short. No one should live and die without fulfilling the purpose of God for his life. Such death could be said to be a bad one.

At the same time no one should die without completing God’s assignment for his life. I love what Apostle Paul said towards the end of his life. In 2 Timothy 2:6-8 (NKJV), he said, “For I am already being poured out as a drink offering, and the time of my departure is at hand. I have fought the good fight, I have finished the race, I have kept the faith. Finally, there is laid up for me the crown of righteousness, which the Lord, the righteous Judge, will give to me on that day, and not to me only but also to all who have loved His appearing.”

COVID-19 Variant: UK Stops Flight From South Africa, Five Other Countries

0
COVID-19 Variant: UK Stops Flight From South Africa, Five Other Countries
COVID-19 Variant: UK Stops Flight From South Africa, Five Other Countries

The United Kingdom will temporarily ban flights from South Africa and five neighboring countries over worries about a new, dramatically different Covid-19 variant recently identified in the region.

According to Bloomberg, the travel restrictions go into effect at noon Friday and are a precautionary measure to keep the spread of the new variant in check, Health Secretary Sajid Javid said. The six African countries will be placed on the U.K.’s red list as of Sunday, requiring travelers to quarantine in hotels upon arrival.

Singapore on Friday also moved to restrict travel from South Africa and nearby nations, following Israel, which acted late Thursday after the U.K. announced its measures.

Scientists are still trying to determine whether the new variant, called B.1.1529, is more transmissible or more lethal than previous ones. What’s clear is that it has the most mutations of any strain yet identified. That’s raised concerns inside South Africa and internationally, with authorities fearing a wave of cases that could increase pressure on already strained healthcare systems.

“As part of our close surveillance of variants across the world, we have become aware of the spread of a new potentially concerning variant,” Javid said in a statement, adding that the new strain it’s now under investigation.

The government of Prime Minister Boris Johnson moved quickly after facing criticism for keeping travel open initially when earlier variants were detected in South Africa and India, allowing them to spread. The U.K. has wrestled with one of the world’s biggest outbreaks of the delta strain since the summer.

The U.K.’s flight ban is a further blow to the airline industry, which was starting to recover from earlier travel restrictions and lockdowns but now faces fresh curbs and a resurgent virus in parts of Europe. The measures mark the biggest change in the U.K.’s Covid travel rules since the so-called traffic light system was overhauled earlier in the autumn to ease border crossings.

From 500 to 700 people daily arrive in the U.K. via South Africa on flights, a number that would normally be expected to increase in the next four to six weeks due to seasonal travel.

In addition to South Africa, the countries covered by the new restrictions are Namibia, Lesotho, Eswatini, Zimbabwe and Botswana.

In South Africa, virologists have detected almost 100 cases linked to the new variant to date, according to Anne von Gottberg, a clinical microbiologist and head of respiratory diseases at the National Institute for Communicable Diseases. No cases have been identified in the U.K., the health department said.

World Health Organization officials have met to discuss the variant, which has also been detected in Botswana, where it’s been found in people who were vaccinated against Covid.

“Armed by our experience and understanding of the alpha and delta variants, we know that early action is far better than late action,” Ewan Birney, deputy director-general of the European Molecular Biology Laboratory, said in a Science Media Centre briefing note. “It may turn out that this variant is not as large a threat as alpha and delta, but the potential consequences of not acting on the possibility it could be are serious.”

The new variant probably evolved during chronic infection of an immuno-compromised person, possibly in an untreated HIV/AIDS patient, said Francois Balloux, director of the UCL Genetics Institute. The world’s biggest number of HIV cases has made it more difficult for South Africa to fight the Covid pandemic, because the virus can linger for longer in people whose immune systems are compromised, potentially offering a bigger window for mutations.

WHO experts are meeting Friday with authorities from South Africa, according to U.K. officials. It will take several weeks to see the impact of the new variant on hospitalizations and deaths and to study how it may interact with vaccines.

(Agency report)

Applause, as The Roses Ministry Gifts Over 2,000 Widows Foodstuff, Others

0
A cross-section of the beneficiaries in a group photograph with Pharm. (Mrs) Regina Ezenwa, and other management staff of The Roses’ Ministry at the 2021 Widow’s Day Programme

It was a carnival-like arena at the secretariat of the Nigeria Population Commission (NPC), Surulere, Lagos, as no fewer than 2,300 widows across the state showered praises on the Coordinator of The Roses Ministry, Pharm. (Mrs) Regina Ezenwa, for being instrumental for their welfare, at the Widow’s Day Programme, 2021.

The Roses Ministry,  a faith-based non-governmental organisation, aimed at alleviating the plights of widows, orphans and vulnerable persons in the society.

The Annual Widow’s Day programme, held on Thursday with the theme “It came to pass”, saw the beneficiaries enjoyed free health screening, donations of food items, clothing materials and drugs. It  had in attendance top management staff of The Roses Ministry, members of the Association of Community Pharmacists of Nigeria (ACPN), Surulere Zone, as well as the security personnel.

Speaking on how she came up with the vision to start the Ministry,  Pharm.(Mrs) Ezenwa, said the ministry was the result of a divine call she received, adding that it had indeed come a long way as the initiative now has several children on scholarship, saying some had graduated, and that the figure would have increased to ten by next year.

Some of the items shared at the 2021 Widow’s Day Programme

On the reason for giving out free drugs to the widows, she said, “We don’t want anybody to die from lack of drugs. You can even ask those around if anybody paid for her drugs. No! Besides, all the pharmacists that dispensed drugs at this programme are volunteers residing or running their stores in Surulere. They even came with free drugs to show solidarity and identify with the programme,” she noted.

She explained further that at the inception of the Widows Programme, some years back,  about 50 widows were in attendance, saying in subsequent years, the number grew to about 100; but by 2016, the number had increased to 1000, which eventually has increased to over 2000 this year. She added that the number keeps rising because virtually all the women were coming along with fellow widows.

“We have empowered the youths through seminars and Bible counselling. Some orphanage homes have also benefited from the Foundation‘s largesse. The ministry will continue to work towards its goal of bringing succour and healing to the homes of these widows while restoring broken marriages and relationships,” she said.

While speaking, Mrs Ugochi Roland-Opara, coordinator of the widows’ department, said the annual event is organised to show love to widows who are helpless and vulnerable, by celebrating them and assisting them to at least put food on their tables by providing them bags of rice, wrapper, bread, and other food items.

“When you look around, you will see that a lot of people go to bed hungry, while a lot do not even know where their next meal would come from, especially widows whose circumstances of losing their husbands has turned them to beggars”, she said

According to her, in order to focus more on the aged and vulnerable women among the lot, Widow’s Day Programme was set aside to celebrate widows and that is part of activities that make up the event, including fellowship and sharing of the Word of God, free medical screening by doctors on ground, free drug dispensing (mostly antimalarial, antibiotics, blood tonic, multivitamins and pain relievers) by volunteer pharmacists and free distribution of household items like bags of rice, textiles, toiletries and vegetable oil.

Roland-Opara also disclosed to Pharmanewsonline how the not-for-profit Ministry started an empowerment programme, which features practical sessions like liquid soap production, beads-making, fashion designing, fish smoking and hairdressing, to train the women.

“We have more than 16 children presently in the universities across the country being sponsored by us and we have many who have graduated, likewise we have those we have empowered and those learning handwork. It has not been easy putting this kind of programme together, but the love to do more has been keeping us going. The world can be a better place if the poor are well catered for, crime will also reduce if everyone has a pot of food at home, and it will be a better place for all of us.

Corroborating Mrs Roland- Opara, Mrs Betty Obialuu, an administrator with The Roses Ministry, said people have been coming on a yearly basis to register irrespective of their tribes, race, colour, denomination and religion, adding that the concern of the Ministry is to ensure they are all taken care of and as well given the message of hope.

“Each of them today will go home with nothing less than a quarter bag of rice, a loaf of bread and six yards of Ankara Cloth. As we speak today, we have 2,300 widows under us  and we have made sure that on monthly basis, we give out things to them, and on a day like this, which Is an annual event, we make it go round to all of them”, she explained.

In her appreciation to The Roses’ Ministry, one of the  widows, Mrs Taiwo Ajala, a businesswoman who lost her husband in 2014, and joined The Roses Ministry in 2015, said she has no regret joining the ministry despite coming from a Muslim background, adding that since she became a member,the Ministry has been catering for her and her family, including her daughter, Oluwadamilola Zainab Ajala, who got a scholarship from The Roses Ministry and presently in 400 Level studying in OAU, Ile-Ife.

“So I am highly grateful to the Ministry and I appreciate God in the life of Mrs Regina Ezenwa, for what she is doing in the lives of we underprivileged. She is a devoted Christian, she is a detribalised Nigerian and a dedicated giver. The Ministry is truly God sent and it has changed my life for good, in fact, my daughter gets N12,000  as monthly allowance even as a student”, she stated.

Also speaking in the same vein, another beneficiary, Mrs Chinwe Maduka, said she got in contact with The Roses’ Ministry 7 years ago after the death of her husband and since then she has been participating in their programmes and activities and her life has changed for the better.

“I got to know about The Roses’ Ministry through a friend, and since then, I have never had any reason to regret knowing them. I am a proud owner of a shop where I make money on daily basis, take care of my three kids and cater for my daily needs. I pray that God will keep strengthening Madam Ezenwa, and all the partners that are supporting this good gesture”, she said.

For Margaret Cyril Akuchi, a first-class graduate of the University of Ado Ekiti, who got a scholarship programme as a result of her mother, Mrs Eucharia Cyril Akuchi, being a member of the Ministry, noted that it was the best thing that ever happened to her in life as she had given up the aspiration to acquire university education after her secondary education.

According to elated Akuchi, the death of her dad in 2007, when she was 14 years would have nailed the coffin to her aspiration to further her education, but the Ministry came on board when all hope was lost and sponsored her throughout the four years.

The programme featured praise and worship, free medical care, counselling and giving out of relief materials, ranging from Bibles, Ankara fabrics, bags of rice, drinks, loaves of bread, vegetable oil, toiletries and drugs to the widows.

 

 

 

 

 

Scientist Associates Aspirin Use with Increased Risk of Heart Failure

0
Scientist Associates Aspirin Use with Increased Risk of Heart Failure
Scientist Associates Aspirin Use with Increased Risk of Heart Failure

A new research published in the ESC Heart Failure Journal,  has found that taking aspirin is associated with a 26 per cent increased risk of heart failure. The other factors associated with it are smoking, obesity, high blood pressure, high cholesterol, diabetes and cardiovascular disease.

“This is the first study to report that among individuals with at least one risk factor for heart failure, those taking aspirin were more likely to subsequently develop the condition than those not using the medication,” said study author Dr Blerim Mujaj of the University of Freiburg, Germany. “While the findings require confirmation, they do indicate that the potential link between aspirin and heart failure needs to be clarified”.

The influence of aspirin on heart failure is controversial. This study aimed to evaluate its relationship with heart failure incidence in people with and without heart disease and assess whether using the drug is related to a new heart failure diagnosis in those at risk.

The analysis included 30,827 individuals at risk for developing heart failure who were enrolled from Western Europe and the US into the HOMAGE study. “At risk” was defined as one or more of the following: smoking, obesity, high blood pressure, high cholesterol, diabetes and cardiovascular disease. Participants were aged 40 years and above and free of heart failure at baseline. Aspirin use was recorded at enrolment and participants were classified as users or non-users. Participants were followed-up for the first incidence of fatal or non-fatal heart failure requiring hospitalization.

The average age of participants was 67 years and 34 per cent were women. At baseline, a total of 7,698 participants (25 per cent) were taking aspirin. During the 5.3-year follow-up, 1,330 participants developed heart failure.

The investigators assessed the association between aspirin use and incident heart failure after adjusting for sex, age, body mass index, smoking, alcohol use, blood pressure, heart rate, blood cholesterol, creatinine, hypertension, diabetes, cardiovascular disease, and treatment with renin-angiotensin-aldosterone-system inhibitors, calcium channel blockers, diuretics, beta-blockers and lipid-lowering drugs. Taking aspirin was independently associated with a 26 per cent raised risk of a new heart failure diagnosis.

To check the consistency of the results, the researchers repeated the analysis after matching aspirin users and non-users for heart failure risk factors. In this matched analysis, aspirin was associated with a 26% raised risk of a new heart failure diagnosis. To check the results further, the analysis was repeated after excluding patients with a history of cardiovascular disease. In 22,690 participants (74 per cent) free of cardiovascular disease, aspirin use was associated with a 27 per cent increased risk of incident heart failure.

Dr Mujaj said that “this was the first large study to investigate the relationship between aspirin use and incident heart failure in individuals with and without heart disease and at least one risk factor. Aspirin is commonly used—in our study one in four participants were taking the medication. In this population, aspirin use was associated with incident heart failure, independent of other risk factors.”

He concluded that “large multinational randomized trials in adults at risk for heart failure are needed to verify these results. Until then, our observations suggest that aspirin should be prescribed with caution in those with heart failure or with risk factors for the condition.”

 

Healthcare Board Urges Nigerians to Ignore COVID-19 Vaccine Myths, Misinformation

0
Healthcare Board Urges Nigerians to Ignore COVID-19 Vaccine Myths, Misinformation

The Federal Capital Territory Primary Health Care Board has urged Nigerians to disregard the myths and misinformation surrounding the safety of the COVID-19 vaccine.

Mr. Francis Okonkwo, of the board, stated this while delivering a lecture at a one-day media orientation workshop on the COVID-19 mass vaccination campaign.

He noted that all the myths making the round on the COVID-19 vaccine were false, noting that they were aimed at discouraging people from taking the vaccines.

The workshop was organised by the board in collaboration with Breakthrough Action Nigeria to seek media partnership in driving the campaign to encourage Nigerians to get vaccinated.

Okonkwo, who spoke on the role of the media in the implementation of the COVID-19 mass vaccination campaign inaugurated on November 18 in the FCT encouraged Nigerians to get vaccinated, saying the vaccine does not change the DNA of individuals as being speculated.

“The news making round that the messenger RNA technology used in making COVID-19 vaccine is new is not true, and the claims that the vaccine contains controversial substance are all falsehood.

“The news that the COVID-19 vaccine magnetises substances at the point where it was taking on the body is just a myth,” he said.

He, however, admitted that the vaccine could react differently in the body of individuals owing to body response or the gene substance, which he said was not the same for every individual.

He, therefore, urged Nigerians who were yet to be vaccinated to disregard the myth surrounding the vaccine and take the vaccines.

He also called on the media to help propagate the campaign about the vaccine, adding that the media were the gatekeepers who had the power to change the narratives about all the myths.

According to him, the COVID-19 vaccine does not hurt, they are safe and efficacious.

He called for action to manage the infodemic, adding that the infodemic challenge was the main issue surrounding the COVID-19 vaccine.

The Head of Advocacy, Communication and Mobilisation, FPHCB, Nana Yusuf, said that the board was targeting 1.5 million Nigerians to be vaccinated in the FCT before December 31.

She called on the media to assist the board by embarking on an aggressive campaign that would reach the nooks and crannies of the FCT and spur all adults from 18 years to get vaccinated.

The Deputy Director, Nursing Services, FPHCB, Mrs. Salome Tor, enumerated some of the challenges hindering health workers in carrying out their duties effectively as it relates to COVID-19 vaccination.

Tor, who was represented by Mrs. Adéyemí Margaret, FCT State Immunisation Officer flays vaccine hesitancy across all segments of people in the society including civil servants and health workers, noting that it is a major problem.

According to her, thousands of Nigerians have negative thinking about this vaccine, adding that there is a need to change the narrative.

Some of the challenges she also identified are poor programme funding, recruitment of ad hoc workers for the vaccination exercise, as well as poor internet services in checking for data.

Others are poor road network to some communities in the FCT, difficulties in accessing first dose vaccination data and insecurity in some parts of the community.

the Head, Media Unit, Breakthrough Action Nigeria, Mr. Eze Eze, pleaded with the media to use all the channels of the communication network to educate Nigerians to get vaccinated.

According to him, the media is now the hope of stakeholders that is being relied upon to help drive the campaign about the vaccine and make Nigerians get vaccinated. 

(NAN)

Global COVID-19 Deaths Hit 5,165,289 With 8,499 New Fatalities

0
Global COVID-19 Deaths Hit 5,165,289 With 8,499 New Fatalities
Global COVID-19 Deaths Hit 5,165,289 With 8,499 New Fatalities

The novel coronavirus has killed at least 5,165,289 people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP at 1100 GMT on Wednesday.

At least 258,299,880 cases of coronavirus have been registered.

The vast majority have recovered, though some have continued to experience symptoms weeks or even months later.

The figures are based on daily reports provided by health authorities in each country. They exclude revisions made by other statistical organisations, which show that the number of deaths is much higher. 

The World Health Organisation estimates that the pandemic’s overall toll could be two to three times higher than official records, due to the excess mortality that is directly and indirectly linked to COVID-19. 

A large number of the less severe or asymptomatic cases also remain undetected, despite intensified testing in many countries. 

On Tuesday, 8,499 new deaths and 763,521 new cases were recorded worldwide. 

Based on the latest reports, the countries with the highest figures for new deaths were Russia with 1,240, followed by the United States with 1,183 and Ukraine with 595.

The United States is the worst-affected country with 773,857 deaths from 47,982,843 cases. 

After the United States, the hardest-hit countries are Brazil with 613,066 deaths from 22,030,182 cases, India with 466,584 deaths from 34,535,763 cases, Mexico with 292,850 deaths from 3,867,976 cases, and Russia with 267,819 deaths from 9,434,393 cases. 

The country with the highest number of deaths compared to its population is Peru with 609 fatalities per 100,000 inhabitants, followed by Bulgaria with 396, Bosnia with 376, Montenegro with 360, North Macedonia with 358, Hungary with 345 and the Czech Republic with 303. 

Latin America and the Caribbean overall has 1,536,155 deaths from 46,506,386 cases, Europe 1,495,319 deaths from 81,955,159 infections, and Asia 891,837 deaths from 56,932,896 cases. 

The United States and Canada have reported 803,394 deaths from 49,754,305 cases, Africa 221,868 deaths from 8,610,351 cases, the Middle East 213,466 deaths from 14,241,215 cases, and Oceania 3,250 deaths from 299,572 cases. 

As a result of corrections by national authorities or late publication of data, the figures updated over the past 24 hours may not correspond exactly to the previous day’s tallies. 

(AFP)